$cno 2021 Q4 10-K

Concept	2021 Q4	2021 Q3	2021 Q2
Revenue	$1.075B	$968.3M	$1.073B
YoY Change	-0.13%	-4.46%	5.81%
Cost Of Revenue		$524.8M	$657.4M
YoY Change		-6.4%	21.67%
Gross Profit		$443.5M	$415.7M
YoY Change		-2.05%	-12.28%
Gross Profit Margin		45.8%	38.74%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$903.1M	$816.6M	$947.5M
YoY Change	-0.69%	-0.83%	7.62%
Operating Profit		$119.3M	$115.6M
YoY Change		-17.89%	13.11%
Interest Expense	-$23.60M	$23.70M	$24.00M
YoY Change	1.29%	0.0%	-15.49%
% of Operating Profit		19.87%	20.76%
Other Income/Expense, Net
YoY Change
Pretax Income	$148.1M	$128.0M	$101.6M
YoY Change	3.21%	-23.08%	-3.61%
Income Tax	$32.30M	$28.20M	$23.60M
% Of Pretax Income	21.81%	22.03%	23.23%
Net Earnings	$115.8M	$99.80M	$78.00M
YoY Change	3.58%	-22.76%	-4.88%
Net Earnings / Revenue	10.77%	10.31%	7.27%
Basic Earnings Per Share	$0.95	$0.79	$0.59
Diluted Earnings Per Share	$0.93	$0.77	$0.58
COMMON SHARES
Basic Shares Outstanding	123.3M shares	126.4M shares	131.0M shares
Diluted Shares Outstanding		129.0M shares	133.8M shares

Concept	2021 Q4	2021 Q3	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$731.7M	$812.6M	$714.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$28.93B	$28.26B	$28.06B
YoY Change	4.87%	5.37%	7.16%
Other Assets	$118.3M	$145.7M	$218.6M
YoY Change	-40.55%	-54.75%	-49.04%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$36.20B	$35.71B	$35.52B
YoY Change	2.45%	3.31%	4.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$4.001B	$4.030B	$3.930B
YoY Change	1.78%	6.46%	3.83%
Other Long-Term Liabilities	$830.9M	$995.3M	$946.5M
YoY Change	1.08%	16.27%	20.11%
Total Long-Term Liabilities	$4.832B	$5.025B	$4.877B
YoY Change	1.66%	8.27%	6.64%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.832B	$5.025B	$4.877B
Total Liabilities	$30.94B	$30.48B	$30.20B
YoY Change	3.65%	3.38%	3.24%
SHAREHOLDERS EQUITY
Retained Earnings	$1.127B	$1.027B	$944.2M
YoY Change	49.83%	56.26%	73.15%
Common Stock	$2.185B	$2.276B	$2.384B
YoY Change	-14.16%	-13.3%	-10.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.260B	$5.233B	$5.324B
YoY Change
Total Liabilities & Shareholders Equity	$36.20B	$35.71B	$35.52B
YoY Change	2.45%	3.31%	4.53%

Concept	2021 Q4	2021 Q3	2021 Q2
OPERATING ACTIVITIES
Net Income	$115.8M	$99.80M	$78.00M
YoY Change	3.58%	-22.76%	-4.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$119.3M	$240.7M	$148.9M
YoY Change	-38.41%	11.02%	-25.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$730.7M	-$245.0M	-$216.4M
YoY Change	309.13%	388.05%	7.45%
Cash From Investing Activities	-$730.7M	-$245.0M	-$216.4M
YoY Change	309.13%	388.05%	7.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	530.5M	102.1M	43.40M
YoY Change	178.92%	64.41%	356.84%
NET CHANGE
Cash From Operating Activities	119.3M	240.7M	148.9M
Cash From Investing Activities	-730.7M	-245.0M	-216.4M
Cash From Financing Activities	530.5M	102.1M	43.40M
Net Change In Cash	-80.90M	97.80M	-24.10M
YoY Change	-139.41%	-57.24%	-425.68%
FREE CASH FLOW
Cash From Operating Activities	$119.3M	$240.7M	$148.9M
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q4	cno	Operating Loss Carryforward Limitation Number Of Shares Purchased By Each Right OperatingLossCarryforwardLimitationNumberOfSharesPurchasedByEachRight	0.001	shares
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-31792
CY2021	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3108137
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	11825 N. Pennsylvania Street
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46032
CY2021	dei	City Area Code CityAreaCode	(317)
CY2021	dei	Local Phone Number LocalPhoneNumber	817-6100
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	3000000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	118466122	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	Indianapolis, Indiana
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	7600000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	2200000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	21867600000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	19921100000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	24805400000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	23383600000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	131100000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	151200000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5600000	USD
CY2021Q4	us-gaap	Investments Investments	28926100000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11800000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1218600000	USD
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1358700000	USD
CY2021Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	120200000	USD
CY2020Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	123000000.0	USD
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	227200000	USD
CY2020Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	232000000.0	USD
CY2021Q4	cno	Investments Held By Variable Interest Entities Allowance For Credit Loss InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss	3700000	USD
CY2020Q4	cno	Investments Held By Variable Interest Entities Allowance For Credit Loss InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss	15100000	USD
CY2021Q4	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1206800000	USD
CY2020Q4	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1211300000	USD
CY2021Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1199600000	USD
CY2020Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1189400000	USD
CY2021Q4	us-gaap	Other Investments OtherInvestments	1224000000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	1146400000	USD
CY2020Q4	us-gaap	Investments Investments	27584300000	USD
CY2021Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	632100000	USD
CY2020Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	937800000	USD
CY2021Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	99600000	USD
CY2020Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	54100000	USD
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	216400000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	205800000	USD
CY2021Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	222600000	USD
CY2020Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	249400000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1112000000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1027800000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	3000000.0	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	4000000.0	USD
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4354300000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4584300000	USD
CY2021Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	118300000	USD
CY2020Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	199400000	USD
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	3900000	USD
CY2020Q4	us-gaap	Separate Account Assets SeparateAccountAssets	4200000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	519100000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	492800000	USD
CY2021Q4	us-gaap	Assets Assets	36204400000	USD
CY2020Q4	us-gaap	Assets Assets	35339900000	USD
CY2021Q4	us-gaap	Policyholder Funds PolicyholderFunds	13689700000	USD
CY2020Q4	us-gaap	Policyholder Funds PolicyholderFunds	12540600000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11670700000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11744200000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	501800000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	561800000	USD
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	246700000	USD
CY2020Q4	us-gaap	Unearned Premiums UnearnedPremiums	252600000	USD
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	3900000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4200000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	830900000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	821800000	USD
CY2021Q4	cno	Investment Borrowings InvestmentBorrowings	1715800000	USD
CY2020Q4	cno	Investment Borrowings InvestmentBorrowings	1642500000	USD
CY2021Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1147900000	USD
CY2020Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1151800000	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	1137300000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	1136200000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	30944700000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	29855700000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120377152	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120377152	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135279119	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135279119	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1200000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1300000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2184200000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2544500000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1947100000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2186100000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1127200000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	752300000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5259700000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5484200000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36204400000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35339900000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	2523400000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	2511300000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	2480800000	USD
CY2021	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	1140200000	USD
CY2020	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	1079000000	USD
CY2019	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	1098000000	USD
CY2021	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	280500000	USD
CY2020	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	143500000	USD
CY2019	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	264900000	USD
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	21300000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-18400000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1700000	USD
CY2021	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-2200000	USD
CY2020	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	-17800000	USD
CY2019	cno	Other Investments Gain Loss OtherInvestmentsGainLoss	29900000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	19100000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-36200000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	28200000	USD
CY2021	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	159000000.0	USD
CY2020	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	123500000	USD
CY2019	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	143900000	USD
CY2021	us-gaap	Revenues Revenues	4122200000	USD
CY2020	us-gaap	Revenues Revenues	3821100000	USD
CY2019	us-gaap	Revenues Revenues	4015800000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2190700000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2157900000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2417000000	USD
CY2021	us-gaap	Interest Expense InterestExpense	95400000	USD
CY2020	us-gaap	Interest Expense InterestExpense	108800000	USD
CY2019	us-gaap	Interest Expense InterestExpense	152300000	USD
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	281100000	USD
CY2020	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	268100000	USD
CY2019	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	232100000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	987300000	USD
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	942000000.0	USD
CY2019	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	932900000	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3554500000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3476800000	USD
CY2019	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3741600000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	567700000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	344300000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	274200000	USD
CY2021	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	126700000	USD
CY2020	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	76500000	USD
CY2019	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	58500000	USD
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34000000.0	USD
CY2019	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-193700000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	441000000.0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	301800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	409400000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128400000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142096000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156040000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.43
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.12
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.62
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131126000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143164000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157148000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.61
CY2021	us-gaap	Net Income Loss NetIncomeLoss	441000000.0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	301800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	409400000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-486700000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1332800000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1830200000	USD
CY2021	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-35500000	USD
CY2020	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	116000000.0	USD
CY2019	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	165600000	USD
CY2021	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	174500000	USD
CY2020	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-204000000.0	USD
CY2019	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-133000000.0	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1115400000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	29400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-27100000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	6300000	USD
CY2021	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	1700000	USD
CY2020	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-2400000	USD
CY2019	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	600000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-304400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1037500000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1525900000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-65400000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	223900000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	331100000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-239000000.0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	813600000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1194800000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	202000000.0	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1604200000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3370900000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	409400000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	331100000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1194900000	USD
CY2019	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	-100000	USD
CY2019	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	-100000	USD
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	252300000	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	67200000	USD
CY2019	cno	Stock Based Compensation StockBasedCompensation	24500000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	301800000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	223900000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	813600000	USD
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	263000000.0	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	67400000	USD
CY2020	cno	Stock Based Compensation StockBasedCompensation	40000000.0	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5484200000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	441000000.0	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-65400000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-239000000.0	USD
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	402400000	USD
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	66100000	USD
CY2021	cno	Stock Based Compensation StockBasedCompensation	42000000.0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5259700000	USD
CY2021	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2341800000	USD
CY2020	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2331000000	USD
CY2019	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	2326000000	USD
CY2021	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1073100000	USD
CY2020	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1097400000	USD
CY2019	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1122300000	USD
CY2021	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	142500000	USD
CY2020	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	123500000	USD
CY2019	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	132600000	USD
CY2021	cno	Insurance Policy Benefits InsurancePolicyBenefits	1661100000	USD
CY2020	cno	Insurance Policy Benefits InsurancePolicyBenefits	1582900000	USD
CY2019	cno	Insurance Policy Benefits InsurancePolicyBenefits	1630100000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	92800000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	111200000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	151200000	USD
CY2021	cno	Policy Acquisition Costs PolicyAcquisitionCosts	298800000	USD
CY2020	cno	Policy Acquisition Costs PolicyAcquisitionCosts	275800000	USD
CY2019	cno	Policy Acquisition Costs PolicyAcquisitionCosts	288700000	USD
CY2021	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	926200000	USD
CY2020	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	818100000	USD
CY2019	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	816600000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-19800000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	28400000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2400000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	598300000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	735500000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	696700000	USD
CY2021	cno	Sales Of Investments SalesOfInvestments	1823600000	USD
CY2020	cno	Sales Of Investments SalesOfInvestments	1480000000	USD
CY2019	cno	Sales Of Investments SalesOfInvestments	2899200000	USD
CY2021	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2880300000	USD
CY2020	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2218300000	USD
CY2019	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	2237700000	USD
CY2021	cno	Purchases Of Investments PurchasesOfInvestments	6135200000	USD
CY2020	cno	Purchases Of Investments PurchasesOfInvestments	4280700000	USD
CY2019	cno	Purchases Of Investments PurchasesOfInvestments	5576400000	USD
CY2021	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-19500000	USD
CY2020	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	13800000	USD
CY2019	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-14100000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	75300000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	39800000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	102000000.0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1526100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-608400000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-555600000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	145800000	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	494200000	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	425000000.0	USD
CY2021	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	0	USD
CY2020	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	0	USD
CY2019	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	6100000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21500000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19000000.0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9200000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	407800000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	268300000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	254500000	USD
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	65700000	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	67000000.0	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	67100000	USD
CY2021	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	2405100000	USD
CY2020	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1620100000	USD
CY2019	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1743100000	USD
CY2021	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1352500000	USD
CY2020	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1235600000	USD
CY2019	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1363900000	USD
CY2021	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	795800000	USD
CY2020	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	498000000.0	USD
CY2019	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	536800000	USD
CY2021	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	722400000	USD
CY2020	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	499800000	USD
CY2019	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	538200000	USD
CY2021	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	5400000	USD
CY2020	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	2100000	USD
CY2019	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	271500000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1000000.0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	667600000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	210100000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-143000000.0	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-260200000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	337200000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1900000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	991900000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	654700000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	656600000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	731700000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	991900000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	654700000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods. For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), allowance for credit losses and other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals. If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2021, we acquired DirectPath, LLC ("DirectPath"), a leading national provider of year-round, technology-driven employee benefits management services to employers and employees. DirectPath provides personalized benefits education, advocacy and transparency, and communications compliance services that help employers reduce healthcare costs and assist employees with making informed benefits decisions. The base purchase price was $50 million with an additional earn‐out if certain financial targets are achieved. The transaction was funded from holding company cash. The amount paid, net of cash held by DirectPath on the date of acquisition, was $46.2 million and is classified as other investing activities on the consolidated statement of cash flows. The net assets acquired totaled $53 million and were primarily comprised of goodwill and other intangible assets of approximately $48 million. The tangible assets acquired and liabilities assumed were recorded at their carrying values which approximated fair value. The intangible assets were recorded at fair value based on various assumptions determined by the Company to be reasonable at the date of acquisition including long-term growth rate, normalized net working capital, internal rate of return, economic life and discount rate. In addition, we recognized advisory and legal expenses of $3 million in connection with the acquisition (of which, $2.5 million was recognized in the first quarter of 2021). The business of DirectPath is included in our fee income segment.</span></div>DirectPath's education services engage and enroll employees in worksite benefits plans through face-to-face, virtual and telephonic enrollment. The Company’s advocacy and transparency services help employees select cost-effective medical providers and resolve claims issues, while enabling employers to reduce administrative and healthcare costs. Its communications compliance services manage governance and regulatory communications for corporate benefits plans.
CY2021	cno	Discount Rate Used To Determine Present Value Of Future Insurance Profits DiscountRateUsedToDeterminePresentValueOfFutureInsuranceProfits	0.12
CY2021	us-gaap	Ceded Premiums Written CededPremiumsWritten	222400000	USD
CY2020	us-gaap	Ceded Premiums Written CededPremiumsWritten	239500000	USD
CY2019	us-gaap	Ceded Premiums Written CededPremiumsWritten	260600000	USD
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	310900000	USD
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	403800000	USD
CY2019	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	439800000	USD
CY2021	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	20300000	USD
CY2020	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	23000000	USD
CY2019	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	25100000	USD
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	24900000	USD
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	31400000	USD
CY2019	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	36400000	USD
CY2021Q4	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	608200000	USD
CY2021Q4	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	241600000	USD
CY2021	cno	Insurance Subsidiaries InsuranceSubsidiaries	3	subsidiary
CY2021	cno	Interest Expense On Fhlb Borrowings InterestExpenseOnFhlbBorrowings	9800000	USD
CY2020	cno	Interest Expense On Fhlb Borrowings InterestExpenseOnFhlbBorrowings	21200000	USD
CY2019	cno	Interest Expense On Fhlb Borrowings InterestExpenseOnFhlbBorrowings	46200000	USD
CY2021	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. Typically, on each policy anniversary date, a new index period begins. We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums. The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. We are required to record the embedded derivatives related to our fixed index annuity products at estimated fair value. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivative is based on the estimated cost to fulfill our commitment to fixed indexed annuity policyholders to purchase a series of annual forward options over the duration of the policy that back the potential return based on a percentage of the amount of increase in the value of the appropriate index. In valuing these options, we are required to make assumptions regarding: (i) future index values to determine both the future notional amounts at each anniversary date and the future prices of the forward starting options; (ii) future annual participation rates; and (iii) non-economic factors related to policy persistency. These assumptions are used to estimate the future cost to purchase the options.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivatives is determined based on the present value of estimated future option costs discounted using a risk-free rate adjusted for our non-performance risk and risk margins for non-capital market inputs. The non-performance risk adjustment is determined by taking into consideration publicly available information related to spreads in the secondary market for debt with credit ratings similar to ours. These observable spreads are then adjusted to reflect the priority of these liabilities and the claim paying ability of the issuing insurance subsidiaries.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk margins are established to capture non-capital market risks which represent the additional compensation a market participant would require to assume the risks related to the uncertainties regarding the embedded derivatives, including future policyholder behavior related to persistency. The determination of the risk margin is highly judgmental given the lack of a market to assume the risks solely related to the embedded derivatives of our fixed index annuity products.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the appropriate risk-free rate and non-performance risk is sensitive to the economic and interest rate environment. Accordingly, the value of the derivative is volatile due to external market sensitivities, which may materially affect net income. Additionally, changes in the judgmental assumptions regarding the appropriate risk margin can significantly impact the value of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.</span></div>
CY2021	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	17300000	USD
CY2020	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	14100000	USD
CY2019	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	24900000	USD
CY2021	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	15500000	USD
CY2020	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	15400000	USD
CY2019	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	7700000	USD
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	61200000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	59400000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21293100000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1559400000	USD
CY2020Q1	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1178700000	USD
CY2020Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	437500000	USD
CY2020Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4781700000	USD
CY2020Q1	us-gaap	Assets Assets	33613100000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	517900000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	4659200000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18443700000	USD
CY2019Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	630900000	USD
CY2019Q1	us-gaap	Assets Assets	31436700000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	193500000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	3367800000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21867600000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	24805400000	USD
CY2021Q4	cno	Available For Sale Securities Fair Value Disclosure Percentage Of Estimated Fair Value AvailableForSaleSecuritiesFairValueDisclosurePercentageOfEstimatedFairValue	1.000
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	2963300000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	3466300000	USD
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	-23100000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-197500000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	-10000000.0	USD
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-8300000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-10200000	USD
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-420200000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-458000000.0	USD
CY2021Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-25500000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-197500000	USD
CY2021Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-539100000	USD
CY2020Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-604500000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1947100000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2186100000	USD
CY2021Q4	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-7300000	USD
CY2021Q4	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-132200000	USD
CY2021Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-25500000	USD
CY2021Q4	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	35800000	USD
CY2020Q4	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-8600000	USD
CY2020Q4	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-133400000	USD
CY2020Q4	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	73700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	80300000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	80500000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1147400000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1205600000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1458400000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1573700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	13409900000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	15913300000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	16096000000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	18773100000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5771600000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	6032300000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21867600000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	24805400000	USD
CY2021	cno	Gross Investment Income Insurance Entity Fixed Maturities GrossInvestmentIncomeInsuranceEntityFixedMaturities	962600000	USD
CY2020	cno	Gross Investment Income Insurance Entity Fixed Maturities GrossInvestmentIncomeInsuranceEntityFixedMaturities	924800000	USD
CY2019	cno	Gross Investment Income Insurance Entity Fixed Maturities GrossInvestmentIncomeInsuranceEntityFixedMaturities	952400000	USD
CY2021	cno	Gross Investment Income Insurance Entity Equity Securities GrossInvestmentIncomeInsuranceEntityEquitySecurities	4300000	USD
CY2020	cno	Gross Investment Income Insurance Entity Equity Securities GrossInvestmentIncomeInsuranceEntityEquitySecurities	3000000.0	USD
CY2019	cno	Gross Investment Income Insurance Entity Equity Securities GrossInvestmentIncomeInsuranceEntityEquitySecurities	3200000	USD
CY2021	cno	Gross Investment Income Insurance Entity Mortgage Loans On Real Estate GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate	65000000.0	USD
CY2020	cno	Gross Investment Income Insurance Entity Mortgage Loans On Real Estate GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate	79500000	USD
CY2019	cno	Gross Investment Income Insurance Entity Mortgage Loans On Real Estate GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate	77100000	USD
CY2021	cno	Gross Investment Income Insurance Entity Policy Loans GrossInvestmentIncomeInsuranceEntityPolicyLoans	8200000	USD
CY2020	cno	Gross Investment Income Insurance Entity Policy Loans GrossInvestmentIncomeInsuranceEntityPolicyLoans	8500000	USD
CY2019	cno	Gross Investment Income Insurance Entity Policy Loans GrossInvestmentIncomeInsuranceEntityPolicyLoans	8300000	USD
CY2021	cno	Gross Investment Income Insurance Entity Other Invested Assets GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets	124800000	USD
CY2020	cno	Gross Investment Income Insurance Entity Other Invested Assets GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets	84000000.0	USD
CY2019	cno	Gross Investment Income Insurance Entity Other Invested Assets GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets	65300000	USD
CY2021	cno	Gross Investment Income Insurance Entity Cash And Cash Equivalents GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents	300000	USD
CY2020	cno	Gross Investment Income Insurance Entity Cash And Cash Equivalents GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents	2600000	USD
CY2019	cno	Gross Investment Income Insurance Entity Cash And Cash Equivalents GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents	13300000	USD
CY2021	cno	Gross Investment Income Insurance Entity Trading Securities GrossInvestmentIncomeInsuranceEntityTradingSecurities	7200000	USD
CY2020	cno	Gross Investment Income Insurance Entity Trading Securities GrossInvestmentIncomeInsuranceEntityTradingSecurities	28100000	USD
CY2019	cno	Gross Investment Income Insurance Entity Trading Securities GrossInvestmentIncomeInsuranceEntityTradingSecurities	8900000	USD
CY2021	cno	Gross Investment Income Insurance Entity Option Income Loss GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss	212000000.0	USD
CY2020	cno	Gross Investment Income Insurance Entity Option Income Loss GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss	35000000.0	USD
CY2019	cno	Gross Investment Income Insurance Entity Option Income Loss GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss	-21200000	USD
CY2021	cno	Gross Investment Income Insurance Entity Increase Decrease In Value Of Options GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions	8900000	USD
CY2020	cno	Gross Investment Income Insurance Entity Increase Decrease In Value Of Options GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions	4500000	USD
CY2019	cno	Gross Investment Income Insurance Entity Increase Decrease In Value Of Options GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions	173100000	USD
CY2021	cno	Gross Investment Income Insurance Entity Other Specialpurpose Portfolios GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios	52400000	USD
CY2020	cno	Gross Investment Income Insurance Entity Other Specialpurpose Portfolios GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios	75900000	USD
CY2019	cno	Gross Investment Income Insurance Entity Other Specialpurpose Portfolios GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios	104100000	USD
CY2021	cno	Gross Investment Income Insurance Entity GrossInvestmentIncomeInsuranceEntity	1445700000	USD
CY2020	cno	Gross Investment Income Insurance Entity GrossInvestmentIncomeInsuranceEntity	1245900000	USD
CY2019	cno	Gross Investment Income Insurance Entity GrossInvestmentIncomeInsuranceEntity	1384500000	USD
CY2021	cno	Investment Income Insurance Entity Investment Expense InvestmentIncomeInsuranceEntityInvestmentExpense	25000000.0	USD
CY2020	cno	Investment Income Insurance Entity Investment Expense InvestmentIncomeInsuranceEntityInvestmentExpense	23400000	USD
CY2019	cno	Investment Income Insurance Entity Investment Expense InvestmentIncomeInsuranceEntityInvestmentExpense	21600000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	1420700000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	1222500000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	1362900000	USD
CY2021Q4	cno	Carrying Value Of Fixed Maturity Investments Not Accruing Investment Income CarryingValueOfFixedMaturityInvestmentsNotAccruingInvestmentIncome	1000000	USD
CY2021Q4	cno	Carrying Value Mortgage Loans Not Accruing Investment Income CarryingValueMortgageLoansNotAccruingInvestmentIncome	0	USD
CY2021	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
CY2020	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	0	USD
CY2019	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-5100000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	19100000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-36200000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	28200000	USD
CY2021	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-7800000	USD
CY2020	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-1700000	USD
CY2019	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	3700000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	19100000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-36200000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	28200000	USD
CY2019	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-5100000	USD
CY2019	cno	Variable Interest Entity Gain Losson Dissolution VariableInterestEntityGainLossonDissolution	-5100000	USD
CY2021Q4	cno	Numberof Investmentsin Defaultor Considered Nonperforming NumberofInvestmentsinDefaultorConsideredNonperforming	0	investment
CY2021	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	493500000	USD
CY2020	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	507100000	USD
CY2019	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	971200000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Within One Year Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCostBasisWithUnrealizedLosses	1000000.0	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Within One Year Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueWithUnrealizedLosses	0	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCostBasisWithUnrealizedLosses	159600000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValueWithUnrealizedLosses	158000000.0	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCostBasisWithUnrealizedLosses	233100000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValueWithUnrealizedLosses	229100000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCostBasisWithUnrealizedLosses	896500000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities After Ten Years Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValueWithUnrealizedLosses	871100000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost With Unrealized Losses Subtotal AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostWithUnrealizedLossesSubtotal	1290200000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Subtotal AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesSubtotal	1258200000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost Basis With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCostBasisWithUnrealizedLosses	1673200000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value With Unrealized Losses AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValueWithUnrealizedLosses	1656500000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Basis With Unrealized Losses Total AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisWithUnrealizedLossesTotal	2963400000	USD
CY2021Q4	cno	Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Total AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesTotal	2914700000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1698600000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	15100000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	122200000	USD

CY2021

dei

Entity Central Index Key

EntityCentralIndexKey

0001224608

CY2021

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2021

CY2021

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2021

dei

Amendment Flag

AmendmentFlag

false

CY2018

us-gaap

Accounting Standards Update Extensible List

AccountingStandardsUpdateExtensibleList

http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member

CY2019

us-gaap

Accounting Standards Update Extensible List

AccountingStandardsUpdateExtensibleList

http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member

CY2021Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherAssets

CY2020Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherAssets

CY2020Q4

us-gaap

Operating Lease Liability Statement Of Financial Position Extensible List

OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherLiabilities

CY2021Q4

us-gaap

Operating Lease Liability Statement Of Financial Position Extensible List

OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherLiabilities

CY2021Q4

cno

Operating Loss Carryforward Limitation Number Of Shares Purchased By Each Right

OperatingLossCarryforwardLimitationNumberOfSharesPurchasedByEachRight

0.001

shares

CY2021

dei

Document Type

DocumentType

10-K

CY2021

dei

Document Annual Report

DocumentAnnualReport

true

CY2021

dei

Document Period End Date

DocumentPeriodEndDate

2021-12-31

CY2021

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2021

dei

Document Transition Report

DocumentTransitionReport

false

CY2021

dei

Entity File Number

EntityFileNumber

001-31792

CY2021

dei

Entity Registrant Name

EntityRegistrantName

CNO Financial Group, Inc.

CY2021

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2021

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

75-3108137

CY2021

dei

Entity Address Address Line1

EntityAddressAddressLine1

11825 N. Pennsylvania Street

CY2021

dei

Entity Address City Or Town

EntityAddressCityOrTown

Carmel,

CY2021

dei

Entity Address State Or Province

EntityAddressStateOrProvince

IN

CY2021

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

46032

CY2021

dei

City Area Code

CityAreaCode

(317)

CY2021

dei

Local Phone Number

LocalPhoneNumber

817-6100

CY2021

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

Yes

CY2021

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2021

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2021

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2021

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2021

dei

Entity Small Business

EntitySmallBusiness

false

CY2021

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2021

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

true

CY2021

dei

Entity Shell Company

EntityShellCompany

false

CY2021Q2

dei

Entity Public Float

EntityPublicFloat

3000000000

USD

CY2022Q1

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

118466122

shares

CY2021

dei

Auditor Firm

AuditorFirmId

238

CY2021

dei

Auditor Name

AuditorName

PricewaterhouseCoopers LLP

CY2021

dei

Auditor Location

AuditorLocation

Indianapolis, Indiana

CY2021Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

7600000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest

DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest

2200000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss

21867600000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss

19921100000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

24805400000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Excluding Accrued Interest

DebtSecuritiesAvailableForSaleExcludingAccruedInterest

23383600000

USD

CY2021Q4

us-gaap

Equity Securities Fv Ni

EquitySecuritiesFvNi

131100000

USD

CY2020Q4

us-gaap

Equity Securities Fv Ni

EquitySecuritiesFvNi

151200000

USD

CY2021Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

5600000

USD

CY2021Q4

us-gaap

Investments

28926100000

USD

CY2020Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

11800000

USD

CY2021Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

1218600000

USD

CY2020Q4

us-gaap

Notes Receivable Net

NotesReceivableNet

1358700000

USD

CY2021Q4

us-gaap

Policy Loans Receivable

PolicyLoansReceivable

120200000

USD

CY2020Q4

us-gaap

Policy Loans Receivable

PolicyLoansReceivable

123000000.0

USD

CY2021Q4

us-gaap

Trading Securities Debt

TradingSecuritiesDebt

227200000

USD

CY2020Q4

us-gaap

Trading Securities Debt

TradingSecuritiesDebt

232000000.0

USD

CY2021Q4

cno

Investments Held By Variable Interest Entities Allowance For Credit Loss

InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss

3700000

USD

CY2020Q4

cno

Investments Held By Variable Interest Entities Allowance For Credit Loss

InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss

15100000

USD

CY2021Q4

cno

Investments Held By Variable Interest Entities Amortized Cost

InvestmentsHeldByVariableInterestEntitiesAmortizedCost

1206800000

USD

CY2020Q4

cno

Investments Held By Variable Interest Entities Amortized Cost

InvestmentsHeldByVariableInterestEntitiesAmortizedCost

1211300000

USD

CY2021Q4

cno

Investments Held By Variable Interest Entities

InvestmentsHeldByVariableInterestEntities

1199600000

USD

CY2020Q4

cno

Investments Held By Variable Interest Entities

InvestmentsHeldByVariableInterestEntities

1189400000

USD

CY2021Q4

us-gaap

Other Investments

OtherInvestments

1224000000

USD

CY2020Q4

us-gaap

Other Investments

OtherInvestments

1146400000

USD

CY2020Q4

us-gaap

Investments

27584300000

USD

CY2021Q4

cno

Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities

CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities

632100000

USD

CY2020Q4

cno

Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities

CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities

937800000

USD

CY2021Q4

cno

Cash And Cash Equivalents Held By Variable Interest Entities

CashAndCashEquivalentsHeldByVariableInterestEntities

99600000

USD

CY2020Q4

cno

Cash And Cash Equivalents Held By Variable Interest Entities

CashAndCashEquivalentsHeldByVariableInterestEntities

54100000

USD

CY2021Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

216400000

USD

CY2020Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

205800000

USD

CY2021Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

222600000

USD

CY2020Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

249400000

USD

CY2021Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1112000000

USD

CY2020Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1027800000

USD

CY2021Q4

us-gaap

Reinsurance Recoverables Allowance

ReinsuranceRecoverablesAllowance

3000000.0

USD

CY2020Q4

us-gaap

Reinsurance Recoverables Allowance

ReinsuranceRecoverablesAllowance

4000000.0

USD

CY2021Q4

us-gaap

Reinsurance Recoverables On Paid Losses

ReinsuranceRecoverablesOnPaidLosses

4354300000

USD

CY2020Q4

us-gaap

Reinsurance Recoverables On Paid Losses

ReinsuranceRecoverablesOnPaidLosses

4584300000

USD

CY2021Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

118300000

USD

CY2020Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

199400000

USD

CY2021Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

3900000

USD

CY2020Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

4200000

USD

CY2021Q4

us-gaap

Other Assets

OtherAssets

519100000

USD

CY2020Q4

us-gaap

Other Assets

OtherAssets

492800000

USD

CY2021Q4

us-gaap

Assets

36204400000

USD

CY2020Q4

us-gaap

Assets

35339900000

USD

CY2021Q4

us-gaap

Policyholder Funds

PolicyholderFunds

13689700000

USD

CY2020Q4

us-gaap

Policyholder Funds

PolicyholderFunds

12540600000

USD

CY2021Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11670700000

USD

CY2020Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11744200000

USD

CY2021Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

501800000

USD

CY2020Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

561800000

USD

CY2021Q4

us-gaap

Unearned Premiums

UnearnedPremiums

246700000

USD

CY2020Q4

us-gaap

Unearned Premiums

UnearnedPremiums

252600000

USD

CY2021Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

3900000

USD

CY2020Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

4200000

USD

CY2021Q4

us-gaap

Other Liabilities

OtherLiabilities

830900000

USD

CY2020Q4

us-gaap

Other Liabilities

OtherLiabilities

821800000

USD

CY2021Q4

cno

Investment Borrowings

InvestmentBorrowings

1715800000

USD

CY2020Q4

cno

Investment Borrowings

InvestmentBorrowings

1642500000

USD

CY2021Q4

cno

Borrowings Related To Variable Interest Entities

BorrowingsRelatedToVariableInterestEntities

1147900000

USD

CY2020Q4

cno

Borrowings Related To Variable Interest Entities

BorrowingsRelatedToVariableInterestEntities

1151800000

USD

CY2021Q4

us-gaap

Notes Payable

NotesPayable

1137300000

USD

CY2020Q4

us-gaap

Notes Payable

NotesPayable

1136200000

USD

CY2021Q4

us-gaap

Liabilities

30944700000

USD

CY2020Q4

us-gaap

Liabilities

29855700000

USD

CY2021Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2020Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2020Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2021Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2021Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

8000000000

shares

CY2020Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

8000000000

shares

CY2021Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

120377152

shares

CY2021Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

120377152

shares

CY2020Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

135279119

shares

CY2020Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

135279119

shares

CY2021Q4

us-gaap

Common Stock Value

CommonStockValue

1200000

USD

CY2020Q4

us-gaap

Common Stock Value

CommonStockValue

1300000

USD

CY2021Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

2184200000

USD

CY2020Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

2544500000

USD

CY2021Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

1947100000

USD

CY2020Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

2186100000

USD

CY2021Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

1127200000

USD

CY2020Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

752300000

USD

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

5259700000

USD

CY2020Q4

us-gaap

Stockholders Equity

StockholdersEquity

5484200000

USD

CY2021Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

36204400000

USD

CY2020Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

35339900000

USD

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2523400000

USD

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2511300000

USD

CY2019

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2480800000

USD

CY2021

cno

Net Investment Income On General Account Invested Assets

NetInvestmentIncomeOnGeneralAccountInvestedAssets

1140200000

USD

CY2020

cno

Net Investment Income On General Account Invested Assets

NetInvestmentIncomeOnGeneralAccountInvestedAssets

1079000000

USD

CY2019

cno

Net Investment Income On General Account Invested Assets

NetInvestmentIncomeOnGeneralAccountInvestedAssets

1098000000

USD

CY2021

cno

Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios

NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios

280500000

USD

CY2020

cno

Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios

NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios

143500000

USD

CY2019

cno

Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios

NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios

264900000

USD

CY2021

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

21300000

USD

CY2020

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

-18400000

USD

CY2019

us-gaap

Realized Investment Gains Losses

RealizedInvestmentGainsLosses

-1700000

USD

CY2021

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-2200000

USD

CY2020

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

-17800000

USD

CY2019

cno

Other Investments Gain Loss

OtherInvestmentsGainLoss

29900000

USD

CY2021

us-gaap

Gain Loss On Investments

GainLossOnInvestments

19100000

USD

CY2020

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-36200000

USD

CY2019

us-gaap

Gain Loss On Investments

GainLossOnInvestments

28200000

USD

CY2021

cno

Fee Revenue And Other Income

FeeRevenueAndOtherIncome

159000000.0

USD

CY2020

cno

Fee Revenue And Other Income

FeeRevenueAndOtherIncome

123500000

USD

CY2019

cno

Fee Revenue And Other Income

FeeRevenueAndOtherIncome

143900000

USD

CY2021

us-gaap

Revenues

4122200000

USD

CY2020

us-gaap

Revenues

3821100000

USD

CY2019

us-gaap

Revenues

4015800000

USD

CY2021

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

2190700000

USD

CY2020

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

2157900000

USD

CY2019

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

2417000000

USD

CY2021

us-gaap

Interest Expense

InterestExpense

95400000

USD

CY2020

us-gaap

Interest Expense

InterestExpense

108800000

USD

CY2019

us-gaap

Interest Expense

InterestExpense

152300000

USD

CY2021

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

281100000

USD

CY2020

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

268100000

USD

CY2019

us-gaap

Amortization Of Deferred Charges

AmortizationOfDeferredCharges

232100000

USD

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

USD

CY2020

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

USD

CY2019

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-7300000

USD

CY2021

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

987300000

USD

CY2020

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

942000000.0

USD

CY2019

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

932900000

USD

CY2021

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3554500000

USD

CY2020

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3476800000

USD

CY2019

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3741600000

USD

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

567700000

USD

CY2020

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

344300000

USD

CY2019

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

274200000

USD

CY2021

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

126700000

USD

CY2020

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

76500000

USD

CY2019

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

58500000

USD

CY2021

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

0

USD

CY2020

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-34000000.0

USD

CY2019

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-193700000

USD

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

USD

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

USD

CY2019

us-gaap

Net Income Loss

NetIncomeLoss

409400000

USD

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

128400000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

142096000

shares

CY2019

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

156040000

shares

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

3.43

CY2020

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.12

CY2019

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

2.62

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

131126000

shares

CY2020

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

143164000

shares

CY2019

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

157148000

shares

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

3.36

CY2020

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.11

CY2019

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

2.61

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

USD

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

USD

CY2019

us-gaap

Net Income Loss

NetIncomeLoss

409400000

USD

CY2021

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

-486700000

USD

CY2020

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

1332800000

USD

CY2019

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

1830200000

USD

CY2021

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax

-35500000

USD

CY2020

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax

116000000.0

USD

CY2019

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax

165600000

USD

CY2021

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax

174500000

USD

CY2020

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax

-204000000.0

USD

CY2019

cno

Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax

OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax

-133000000.0

USD

CY2020

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

1115400000

USD

CY2021

us-gaap

Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

29400000

USD

CY2020

us-gaap

Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

-27100000

USD

CY2019

us-gaap

Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

6300000

USD

CY2021

cno

Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax

1700000

USD

CY2020

cno

Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax

-2400000

USD

CY2019

cno

Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax

OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax

600000

USD

CY2021

us-gaap

Other Comprehensive Income Loss Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent

-304400000

USD

CY2020

us-gaap

Other Comprehensive Income Loss Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent

1037500000

USD

CY2019

us-gaap

Other Comprehensive Income Loss Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent

1525900000

USD

CY2021

us-gaap

Other Comprehensive Income Loss Tax Portion Attributable To Parent1

OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

-65400000

USD

CY2020

us-gaap

Other Comprehensive Income Loss Tax Portion Attributable To Parent1

OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

223900000

USD

CY2019

us-gaap

Other Comprehensive Income Loss Tax Portion Attributable To Parent1

OtherComprehensiveIncomeLossTaxPortionAttributableToParent1

331100000

USD

CY2021

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

-239000000.0

USD

CY2020

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

813600000

USD

CY2019

us-gaap

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

1194800000

USD

CY2021

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

202000000.0

USD

CY2019

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

1604200000

USD

CY2018Q4

us-gaap

Stockholders Equity

StockholdersEquity

3370900000

USD

CY2019

us-gaap

Net Income Loss

NetIncomeLoss

409400000

USD

CY2019

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

331100000

USD

CY2019

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

1194900000

USD

CY2019

cno

Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax

NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax

-100000

USD

CY2019

cno

Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale

NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale

-100000

USD

CY2019

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

252300000

USD

CY2019

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

67200000

USD

CY2019

cno

Stock Based Compensation

StockBasedCompensation

24500000

USD

CY2019Q4

us-gaap

Stockholders Equity

StockholdersEquity

4677000000

USD

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

USD

CY2020

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

223900000

USD

CY2020

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

813600000

USD

CY2020

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

263000000.0

USD

CY2020

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

67400000

USD

CY2020

cno

Stock Based Compensation

StockBasedCompensation

40000000.0

USD

CY2020Q4

us-gaap

Stockholders Equity

StockholdersEquity

5484200000

USD

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

USD

CY2021

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

-65400000

USD

CY2021

us-gaap

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax

OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

-239000000.0

USD

CY2021

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

402400000

USD

CY2021

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

66100000

USD

CY2021

cno

Stock Based Compensation

StockBasedCompensation

42000000.0

USD

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

5259700000

USD

CY2021

us-gaap

Proceeds From Insurance Premiums Collected

ProceedsFromInsurancePremiumsCollected

2341800000

USD

CY2020

us-gaap

Proceeds From Insurance Premiums Collected

ProceedsFromInsurancePremiumsCollected

2331000000

USD

CY2019

us-gaap

Proceeds From Insurance Premiums Collected

ProceedsFromInsurancePremiumsCollected

2326000000

USD

CY2021

us-gaap

Proceeds From Interest And Dividends Received

ProceedsFromInterestAndDividendsReceived

1073100000

USD

CY2020

us-gaap

Proceeds From Interest And Dividends Received

ProceedsFromInterestAndDividendsReceived

1097400000

USD

CY2019

us-gaap

Proceeds From Interest And Dividends Received

ProceedsFromInterestAndDividendsReceived

1122300000

USD

CY2021

us-gaap

Proceeds From Fees Received

ProceedsFromFeesReceived

142500000

USD

CY2020

us-gaap

Proceeds From Fees Received

ProceedsFromFeesReceived

123500000

USD

CY2019

us-gaap

Proceeds From Fees Received

ProceedsFromFeesReceived

132600000

USD

CY2021

cno

Insurance Policy Benefits

InsurancePolicyBenefits

1661100000

USD

CY2020

cno

Insurance Policy Benefits

InsurancePolicyBenefits

1582900000

USD

CY2019

cno

Insurance Policy Benefits

InsurancePolicyBenefits

1630100000

USD

CY2021

us-gaap

Interest Paid Net

InterestPaidNet

92800000

USD

CY2020

us-gaap

Interest Paid Net

InterestPaidNet

111200000

USD

CY2019

us-gaap

Interest Paid Net

InterestPaidNet

151200000

USD

CY2021

cno

Policy Acquisition Costs

PolicyAcquisitionCosts

298800000

USD

CY2020

cno

Policy Acquisition Costs

PolicyAcquisitionCosts

275800000

USD

CY2019

cno

Policy Acquisition Costs

PolicyAcquisitionCosts

288700000

USD

CY2021

us-gaap

Payments For Other Operating Activities

PaymentsForOtherOperatingActivities

926200000

USD

CY2020

us-gaap

Payments For Other Operating Activities

PaymentsForOtherOperatingActivities

818100000

USD

CY2019

us-gaap

Payments For Other Operating Activities

PaymentsForOtherOperatingActivities

816600000

USD

CY2021

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

-19800000

USD

CY2020

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

28400000

USD

CY2019

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

-2400000

USD

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

598300000

USD

CY2020

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

735500000

USD

CY2019

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

696700000

USD

CY2021

cno

Sales Of Investments

SalesOfInvestments

1823600000

USD

CY2020

cno

Sales Of Investments

SalesOfInvestments

1480000000

USD

CY2019

cno

Sales Of Investments

SalesOfInvestments

2899200000

USD

CY2021

cno

Maturities And Redemptions Of Investments

MaturitiesAndRedemptionsOfInvestments

2880300000

USD

CY2020

cno

Maturities And Redemptions Of Investments

MaturitiesAndRedemptionsOfInvestments

2218300000

USD

CY2019

cno

Maturities And Redemptions Of Investments

MaturitiesAndRedemptionsOfInvestments

2237700000

USD

CY2021

cno

Purchases Of Investments

PurchasesOfInvestments

6135200000

USD

CY2020

cno

Purchases Of Investments

PurchasesOfInvestments

4280700000

USD

CY2019

cno

Purchases Of Investments

PurchasesOfInvestments

5576400000

USD

CY2021

us-gaap

Proceeds From Payments For Trading Securities

ProceedsFromPaymentsForTradingSecurities

-19500000

USD

CY2020

us-gaap

Proceeds From Payments For Trading Securities

ProceedsFromPaymentsForTradingSecurities

13800000

USD

CY2019

us-gaap

Proceeds From Payments For Trading Securities

ProceedsFromPaymentsForTradingSecurities

-14100000

USD

CY2021

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

75300000

USD

CY2020

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

39800000

USD

CY2019

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

102000000.0

USD

CY2021

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-1526100000

USD

CY2020

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-608400000

USD

CY2019

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-555600000

USD

CY2021

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

USD

CY2020

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

145800000

USD

CY2019

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

494200000

USD

CY2021

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

0

USD

CY2020

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

0

USD

CY2019

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

425000000.0

USD

CY2021

cno

Expenses Related To Debt Modification And Extinguishment Of Debt

ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt

0

USD

CY2020

cno

Expenses Related To Debt Modification And Extinguishment Of Debt

ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt

0

USD

CY2019

cno

Expenses Related To Debt Modification And Extinguishment Of Debt

ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt

6100000

USD

CY2021

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

21500000

USD

CY2020

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

19000000.0

USD

CY2019

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

9200000

USD

CY2021

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

407800000

USD

CY2020

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

268300000

USD

CY2019

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

254500000

USD

CY2021

us-gaap

Payments Of Dividends

PaymentsOfDividends

65700000

USD

CY2020

us-gaap

Payments Of Dividends

PaymentsOfDividends

67000000.0

USD

CY2019

us-gaap

Payments Of Dividends

PaymentsOfDividends

67100000

USD

CY2021

us-gaap

Proceeds From Annuities And Investment Certificates

ProceedsFromAnnuitiesAndInvestmentCertificates

2405100000

USD

CY2020

us-gaap

Proceeds From Annuities And Investment Certificates

ProceedsFromAnnuitiesAndInvestmentCertificates

1620100000

USD

CY2019

us-gaap

Proceeds From Annuities And Investment Certificates

ProceedsFromAnnuitiesAndInvestmentCertificates

1743100000

USD

CY2021

us-gaap

Repayments Of Annuities And Investment Certificates

RepaymentsOfAnnuitiesAndInvestmentCertificates

1352500000

USD

CY2020

us-gaap

Repayments Of Annuities And Investment Certificates

RepaymentsOfAnnuitiesAndInvestmentCertificates

1235600000

USD

CY2019

us-gaap

Repayments Of Annuities And Investment Certificates

RepaymentsOfAnnuitiesAndInvestmentCertificates

1363900000

USD

CY2021

us-gaap

Proceeds From Federal Home Loan Bank Borrowings

ProceedsFromFederalHomeLoanBankBorrowings

795800000

USD

CY2020

us-gaap

Proceeds From Federal Home Loan Bank Borrowings

ProceedsFromFederalHomeLoanBankBorrowings

498000000.0

USD

CY2019

us-gaap

Proceeds From Federal Home Loan Bank Borrowings

ProceedsFromFederalHomeLoanBankBorrowings

536800000

USD

CY2021

us-gaap

Repayments Of Federal Home Loan Bank Borrowings

RepaymentsOfFederalHomeLoanBankBorrowings

722400000

USD

CY2020

us-gaap

Repayments Of Federal Home Loan Bank Borrowings

RepaymentsOfFederalHomeLoanBankBorrowings

499800000

USD

CY2019

us-gaap

Repayments Of Federal Home Loan Bank Borrowings

RepaymentsOfFederalHomeLoanBankBorrowings

538200000

USD

CY2021

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities

5400000

USD

CY2020

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities

2100000

USD

CY2019

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities

271500000

USD

CY2021

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

1000000.0

USD

CY2020

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

0

USD

CY2019

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

0

USD

CY2021

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

667600000

USD

CY2020

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

210100000

USD

CY2019

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-143000000.0

USD

CY2021

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-260200000

USD

CY2020

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

337200000

USD

CY2019

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-1900000

USD

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

991900000

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

654700000

USD

CY2018Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

656600000

USD

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

731700000

USD

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

991900000

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

654700000

USD

CY2021

us-gaap

Use Of Estimates

UseOfEstimates

<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods. For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), allowance for credit losses and other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals. If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2021, we acquired DirectPath, LLC ("DirectPath"), a leading national provider of year-round, technology-driven employee benefits management services to employers and employees. DirectPath provides personalized benefits education, advocacy and transparency, and communications compliance services that help employers reduce healthcare costs and assist employees with making informed benefits decisions. The base purchase price was $50 million with an additional earn‐out if certain financial targets are achieved. The transaction was funded from holding company cash. The amount paid, net of cash held by DirectPath on the date of acquisition, was $46.2 million and is classified as other investing activities on the consolidated statement of cash flows. The net assets acquired totaled $53 million and were primarily comprised of goodwill and other intangible assets of approximately $48 million. The tangible assets acquired and liabilities assumed were recorded at their carrying values which approximated fair value. The intangible assets were recorded at fair value based on various assumptions determined by the Company to be reasonable at the date of acquisition including long-term growth rate, normalized net working capital, internal rate of return, economic life and discount rate. In addition, we recognized advisory and legal expenses of $3 million in connection with the acquisition (of which, $2.5 million was recognized in the first quarter of 2021). The business of DirectPath is included in our fee income segment.</span></div>DirectPath's education services engage and enroll employees in worksite benefits plans through face-to-face, virtual and telephonic enrollment. The Company’s advocacy and transparency services help employees select cost-effective medical providers and resolve claims issues, while enabling employers to reduce administrative and healthcare costs. Its communications compliance services manage governance and regulatory communications for corporate benefits plans.

CY2021

cno

Discount Rate Used To Determine Present Value Of Future Insurance Profits

DiscountRateUsedToDeterminePresentValueOfFutureInsuranceProfits

0.12

CY2021

us-gaap

Ceded Premiums Written

CededPremiumsWritten

222400000

USD

CY2020

us-gaap

Ceded Premiums Written

CededPremiumsWritten

239500000

USD

CY2019

us-gaap

Ceded Premiums Written

CededPremiumsWritten

260600000

USD

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

310900000

USD

CY2020

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

403800000

USD

CY2019

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

439800000

USD

CY2021

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

20300000

USD

CY2020

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

23000000

USD

CY2019

us-gaap

Assumed Premiums Written

AssumedPremiumsWritten

25100000

USD

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

24900000

USD

CY2020

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

31400000

USD

CY2019

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

36400000

USD

CY2021Q4

cno

Investments Held In Limited Partnerships

InvestmentsHeldInLimitedPartnerships

608200000

USD

CY2021Q4

cno

Unfunded Commitmentsto Limited Partnerships

UnfundedCommitmentstoLimitedPartnerships

241600000

USD

CY2021

cno

Insurance Subsidiaries

InsuranceSubsidiaries

3

subsidiary

CY2021

cno

Interest Expense On Fhlb Borrowings

InterestExpenseOnFhlbBorrowings

9800000

USD

CY2020

cno

Interest Expense On Fhlb Borrowings

InterestExpenseOnFhlbBorrowings

21200000

USD

CY2019

cno

Interest Expense On Fhlb Borrowings

InterestExpenseOnFhlbBorrowings

46200000

USD

CY2021

us-gaap

Derivatives Methods Of Accounting Nonhedging Derivatives

DerivativesMethodsOfAccountingNonhedgingDerivatives

<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period. Typically, on each policy anniversary date, a new index period begins. We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums. The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. We are required to record the embedded derivatives related to our fixed index annuity products at estimated fair value. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivative is based on the estimated cost to fulfill our commitment to fixed indexed annuity policyholders to purchase a series of annual forward options over the duration of the policy that back the potential return based on a percentage of the amount of increase in the value of the appropriate index. In valuing these options, we are required to make assumptions regarding: (i) future index values to determine both the future notional amounts at each anniversary date and the future prices of the forward starting options; (ii) future annual participation rates; and (iii) non-economic factors related to policy persistency. These assumptions are used to estimate the future cost to purchase the options.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the embedded derivatives is determined based on the present value of estimated future option costs discounted using a risk-free rate adjusted for our non-performance risk and risk margins for non-capital market inputs. The non-performance risk adjustment is determined by taking into consideration publicly available information related to spreads in the secondary market for debt with credit ratings similar to ours. These observable spreads are then adjusted to reflect the priority of these liabilities and the claim paying ability of the issuing insurance subsidiaries.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk margins are established to capture non-capital market risks which represent the additional compensation a market participant would require to assume the risks related to the uncertainties regarding the embedded derivatives, including future policyholder behavior related to persistency. The determination of the risk margin is highly judgmental given the lack of a market to assume the risks solely related to the embedded derivatives of our fixed index annuity products.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the appropriate risk-free rate and non-performance risk is sensitive to the economic and interest rate environment. Accordingly, the value of the derivative is volatile due to external market sensitivities, which may materially affect net income. Additionally, changes in the judgmental assumptions regarding the appropriate risk margin can significantly impact the value of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.</span></div>

CY2021

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

17300000

USD

CY2020

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

14100000

USD

CY2019

us-gaap

Deferred Sales Inducements Additions

DeferredSalesInducementsAdditions

24900000

USD

CY2021

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

15500000

USD

CY2020

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

15400000

USD

CY2019

us-gaap

Deferred Sales Inducements Amortization Expense

DeferredSalesInducementsAmortizationExpense

7700000

USD

CY2021Q4

us-gaap

Deferred Sales Inducements Net

DeferredSalesInducementsNet

61200000

USD

CY2020Q4

us-gaap

Deferred Sales Inducements Net

DeferredSalesInducementsNet

59400000

USD

CY2020Q1

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

21293100000

USD

CY2020Q1

us-gaap

Notes Receivable Net

NotesReceivableNet

1559400000

USD

CY2020Q1

cno

Investments Held By Variable Interest Entities

InvestmentsHeldByVariableInterestEntities

1178700000

USD

CY2020Q1

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

437500000

USD

CY2020Q1

us-gaap

Reinsurance Recoverables On Paid Losses

ReinsuranceRecoverablesOnPaidLosses

4781700000

USD

CY2020Q1

us-gaap

Assets

33613100000

USD

CY2020Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

517900000

USD

CY2020Q1

us-gaap

Stockholders Equity

StockholdersEquity

4659200000

USD

CY2019Q1

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

18443700000

USD

CY2019Q1

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

630900000

USD

CY2019Q1

us-gaap

Assets

31436700000

USD

CY2019Q1

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

193500000

USD

CY2019Q1

us-gaap

Stockholders Equity

StockholdersEquity

3367800000

USD

CY2021Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

21867600000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

24805400000

USD

CY2021Q4

cno

Available For Sale Securities Fair Value Disclosure Percentage Of Estimated Fair Value

AvailableForSaleSecuritiesFairValueDisclosurePercentageOfEstimatedFairValue

1.000

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses

2963300000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses

3466300000

USD

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses

-23100000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-197500000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses

AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses

-10000000.0

USD

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits

AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits

-8300000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits

AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits

-10200000

USD

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs

AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts

-420200000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs

AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts

-458000000.0

USD

CY2021Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-25500000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-197500000

USD

CY2021Q4

cno

Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities

AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities

-539100000

USD

CY2020Q4

cno

Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities

AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities

-604500000

USD

CY2021Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

1947100000

USD

CY2020Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

2186100000

USD

CY2021Q4

cno

Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-7300000

USD

CY2021Q4

cno

Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-132200000

USD

CY2021Q4

cno

Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-25500000

USD

CY2021Q4

cno

Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

35800000

USD

CY2020Q4

cno

Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-8600000

USD

CY2020Q4

cno

Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

-133400000

USD

CY2020Q4

cno

Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized

IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized

73700000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

80300000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

80500000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

1147400000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

1205600000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost

1458400000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue

1573700000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities After Ten Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost

13409900000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities After Ten Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue

15913300000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities

16096000000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities

AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities

18773100000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost

5771600000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue

6032300000

USD

CY2021Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

21867600000

USD

CY2021Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

24805400000

USD

CY2021

cno

Gross Investment Income Insurance Entity Fixed Maturities

GrossInvestmentIncomeInsuranceEntityFixedMaturities

962600000

USD

CY2020

cno

Gross Investment Income Insurance Entity Fixed Maturities

GrossInvestmentIncomeInsuranceEntityFixedMaturities

924800000

USD

CY2019

cno

Gross Investment Income Insurance Entity Fixed Maturities

GrossInvestmentIncomeInsuranceEntityFixedMaturities

952400000

USD

CY2021

cno

Gross Investment Income Insurance Entity Equity Securities

GrossInvestmentIncomeInsuranceEntityEquitySecurities

4300000

USD

CY2020

cno

Gross Investment Income Insurance Entity Equity Securities

GrossInvestmentIncomeInsuranceEntityEquitySecurities

3000000.0

USD

CY2019

cno

Gross Investment Income Insurance Entity Equity Securities

GrossInvestmentIncomeInsuranceEntityEquitySecurities

3200000

USD

CY2021

cno

Gross Investment Income Insurance Entity Mortgage Loans On Real Estate

GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate

65000000.0

USD

CY2020

cno

Gross Investment Income Insurance Entity Mortgage Loans On Real Estate

GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate

79500000

USD

CY2019

cno

Gross Investment Income Insurance Entity Mortgage Loans On Real Estate

GrossInvestmentIncomeInsuranceEntityMortgageLoansOnRealEstate

77100000

USD

CY2021

cno

Gross Investment Income Insurance Entity Policy Loans

GrossInvestmentIncomeInsuranceEntityPolicyLoans

8200000

USD

CY2020

cno

Gross Investment Income Insurance Entity Policy Loans

GrossInvestmentIncomeInsuranceEntityPolicyLoans

8500000

USD

CY2019

cno

Gross Investment Income Insurance Entity Policy Loans

GrossInvestmentIncomeInsuranceEntityPolicyLoans

8300000

USD

CY2021

cno

Gross Investment Income Insurance Entity Other Invested Assets

GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets

124800000

USD

CY2020

cno

Gross Investment Income Insurance Entity Other Invested Assets

GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets

84000000.0

USD

CY2019

cno

Gross Investment Income Insurance Entity Other Invested Assets

GrossInvestmentIncomeInsuranceEntityOtherInvestedAssets

65300000

USD

CY2021

cno

Gross Investment Income Insurance Entity Cash And Cash Equivalents

GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents

300000

USD

CY2020

cno

Gross Investment Income Insurance Entity Cash And Cash Equivalents

GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents

2600000

USD

CY2019

cno

Gross Investment Income Insurance Entity Cash And Cash Equivalents

GrossInvestmentIncomeInsuranceEntityCashAndCashEquivalents

13300000

USD

CY2021

cno

Gross Investment Income Insurance Entity Trading Securities

GrossInvestmentIncomeInsuranceEntityTradingSecurities

7200000

USD

CY2020

cno

Gross Investment Income Insurance Entity Trading Securities

GrossInvestmentIncomeInsuranceEntityTradingSecurities

28100000

USD

CY2019

cno

Gross Investment Income Insurance Entity Trading Securities

GrossInvestmentIncomeInsuranceEntityTradingSecurities

8900000

USD

CY2021

cno

Gross Investment Income Insurance Entity Option Income Loss

GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss

212000000.0

USD

CY2020

cno

Gross Investment Income Insurance Entity Option Income Loss

GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss

35000000.0

USD

CY2019

cno

Gross Investment Income Insurance Entity Option Income Loss

GrossInvestmentIncomeInsuranceEntityOptionIncomeLoss

-21200000

USD

CY2021

cno

Gross Investment Income Insurance Entity Increase Decrease In Value Of Options

GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions

8900000

USD

CY2020

cno

Gross Investment Income Insurance Entity Increase Decrease In Value Of Options

GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions

4500000

USD

CY2019

cno

Gross Investment Income Insurance Entity Increase Decrease In Value Of Options

GrossInvestmentIncomeInsuranceEntityIncreaseDecreaseInValueOfOptions

173100000

USD

CY2021

cno

Gross Investment Income Insurance Entity Other Specialpurpose Portfolios

GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios

52400000

USD

CY2020

cno

Gross Investment Income Insurance Entity Other Specialpurpose Portfolios

GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios

75900000

USD

CY2019

cno

Gross Investment Income Insurance Entity Other Specialpurpose Portfolios

GrossInvestmentIncomeInsuranceEntityOtherSpecialpurposePortfolios

104100000

USD

CY2021

cno

Gross Investment Income Insurance Entity

GrossInvestmentIncomeInsuranceEntity

1445700000

USD

CY2020

cno

Gross Investment Income Insurance Entity

GrossInvestmentIncomeInsuranceEntity

1245900000

USD

CY2019

cno

Gross Investment Income Insurance Entity

GrossInvestmentIncomeInsuranceEntity

1384500000

USD

CY2021

cno

Investment Income Insurance Entity Investment Expense

InvestmentIncomeInsuranceEntityInvestmentExpense

25000000.0

USD

CY2020

cno

Investment Income Insurance Entity Investment Expense

InvestmentIncomeInsuranceEntityInvestmentExpense

23400000

USD

CY2019

cno

Investment Income Insurance Entity Investment Expense

InvestmentIncomeInsuranceEntityInvestmentExpense

21600000

USD

CY2021

us-gaap

Net Investment Income

NetInvestmentIncome

1420700000

USD

CY2020

us-gaap

Net Investment Income

NetInvestmentIncome

1222500000

USD

CY2019

us-gaap

Net Investment Income

NetInvestmentIncome

1362900000

USD

CY2021Q4

cno

Carrying Value Of Fixed Maturity Investments Not Accruing Investment Income

CarryingValueOfFixedMaturityInvestmentsNotAccruingInvestmentIncome

1000000

USD

CY2021Q4

cno

Carrying Value Mortgage Loans Not Accruing Investment Income

CarryingValueMortgageLoansNotAccruingInvestmentIncome

0

USD

CY2021

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

0

USD

CY2020

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

0

USD

CY2019

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

-5100000

USD

CY2021

us-gaap

Gain Loss On Investments

GainLossOnInvestments

19100000

USD

CY2020

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-36200000

USD

CY2019

us-gaap

Gain Loss On Investments

GainLossOnInvestments

28200000

USD

CY2021

us-gaap

Increase Decrease In Equity Securities Fv Ni

IncreaseDecreaseInEquitySecuritiesFvNi

-7800000

USD

CY2020

us-gaap

Increase Decrease In Equity Securities Fv Ni

IncreaseDecreaseInEquitySecuritiesFvNi

-1700000

USD

CY2019

us-gaap

Increase Decrease In Equity Securities Fv Ni

IncreaseDecreaseInEquitySecuritiesFvNi

3700000

USD

CY2021

us-gaap

Gain Loss On Investments

GainLossOnInvestments

19100000

USD

CY2020

us-gaap

Gain Loss On Investments

GainLossOnInvestments

-36200000

USD

CY2019

us-gaap

Gain Loss On Investments

GainLossOnInvestments

28200000

USD

CY2019

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

-5100000

USD

CY2019

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

-5100000

USD

CY2021Q4

cno

Numberof Investmentsin Defaultor Considered Nonperforming

NumberofInvestmentsinDefaultorConsideredNonperforming

0

investment

CY2021

cno

Available For Sale Securities Value Of Securities Sold

AvailableForSaleSecuritiesValueOfSecuritiesSold

493500000

USD

CY2020

cno

Available For Sale Securities Value Of Securities Sold

AvailableForSaleSecuritiesValueOfSecuritiesSold

507100000

USD

CY2019

cno

Available For Sale Securities Value Of Securities Sold

AvailableForSaleSecuritiesValueOfSecuritiesSold

971200000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Within One Year Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCostBasisWithUnrealizedLosses

1000000.0

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Within One Year Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueWithUnrealizedLosses

0

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCostBasisWithUnrealizedLosses

159600000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValueWithUnrealizedLosses

158000000.0

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCostBasisWithUnrealizedLosses

233100000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValueWithUnrealizedLosses

229100000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities After Ten Years Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCostBasisWithUnrealizedLosses

896500000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities After Ten Years Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValueWithUnrealizedLosses

871100000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Amortized Cost With Unrealized Losses Subtotal

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostWithUnrealizedLossesSubtotal

1290200000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Subtotal

AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesSubtotal

1258200000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost Basis With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCostBasisWithUnrealizedLosses

1673200000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value With Unrealized Losses

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValueWithUnrealizedLosses

1656500000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Amortized Cost Basis With Unrealized Losses Total

AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisWithUnrealizedLossesTotal

2963400000

USD

CY2021Q4

cno

Available For Sale Securities Debt Maturities Fair Value With Unrealized Losses Total

AvailableForSaleSecuritiesDebtMaturitiesFairValueWithUnrealizedLossesTotal

2914700000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

1698600000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

15100000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

122200000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

3400000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position

DebtSecuritiesAvailableForSaleUnrealizedLossPosition

1820800000

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss

18500000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

885000000.0

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

16300000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

324800000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

7200000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position

DebtSecuritiesAvailableForSaleUnrealizedLossPosition

1209800000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss

23500000

USD

CY2019Q4

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAllowanceForCreditLoss

2100000

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded

25700000

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase

DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal

-24100000

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Securities Sold

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold

1500000

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery

0

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Writeoff

DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff

0

USD

CY2020

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery

0

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAllowanceForCreditLoss

2200000

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded

6300000

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase

DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal

DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal

0

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Securities Sold

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold

900000

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery

0

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Writeoff

DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff

0

USD

CY2021

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss Recovery

DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery

0

USD

CY2021Q4

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAllowanceForCreditLoss

7600000

USD

CY2021Q4

cno

Available For Sale Securities Structured Securities Fair Value

AvailableForSaleSecuritiesStructuredSecuritiesFairValue

6000000000

USD

CY2021Q4

cno

Available For Sale Securities Structured Securities Fair Value Percentage Of All Fixed Maturity Securities

AvailableForSaleSecuritiesStructuredSecuritiesFairValuePercentageOfAllFixedMaturitySecurities

0.243

CY2021Q4

cno

Available For Sale Securities Structured Securities Amortized Cost Basis

AvailableForSaleSecuritiesStructuredSecuritiesAmortizedCostBasis

5771600000

USD

CY2021Q4

cno

Available For Sale Securities Structured Securities Fair Value

AvailableForSaleSecuritiesStructuredSecuritiesFairValue

6032300000

USD

CY2021Q4

cno

Available For Sale Securities Structured Securities Fair Value Percentage Of All Fixed Maturity Securities

AvailableForSaleSecuritiesStructuredSecuritiesFairValuePercentageOfAllFixedMaturitySecurities

0.243

CY2021Q4

cno

Number Of Additional States Greater Than Specified Percentage Of Mortgage Loan Balance

NumberOfAdditionalStatesGreaterThanSpecifiedPercentageOfMortgageLoanBalance

0

state

CY2019Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

6700000

USD

CY2020

us-gaap

Provision For Loan Losses Expensed

ProvisionForLoanLossesExpensed

5100000

USD

CY2020

us-gaap

Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase

FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

USD

CY2020

us-gaap

Financing Receivable Allowance For Credit Losses Write Offs

FinancingReceivableAllowanceForCreditLossesWriteOffs

0

USD

CY2020

us-gaap

Financing Receivable Allowance For Credit Losses Recovery

FinancingReceivableAllowanceForCreditLossesRecovery

0

USD

CY2020Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

11800000

USD

CY2021

us-gaap

Provision For Loan Losses Expensed

ProvisionForLoanLossesExpensed

-6200000

USD

CY2021

us-gaap

Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase

FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease

0

USD

CY2021

us-gaap

Financing Receivable Allowance For Credit Losses Write Offs

FinancingReceivableAllowanceForCreditLossesWriteOffs

0

USD

CY2021

us-gaap

Financing Receivable Allowance For Credit Losses Recovery

FinancingReceivableAllowanceForCreditLossesRecovery

0

USD

CY2021Q4

us-gaap

Financing Receivable Allowance For Credit Losses

FinancingReceivableAllowanceForCreditLosses

5600000

USD

CY2021Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

38800000

USD

CY2020Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

40100000

USD

CY2021Q4

cno

Numberof Investmentsin Defaultor Considered Nonperforming

NumberofInvestmentsinDefaultorConsideredNonperforming

0

investment

CY2020Q4

cno

Numberof Investmentsin Defaultor Considered Nonperforming

NumberofInvestmentsinDefaultorConsideredNonperforming

0

investment

CY2021

cno

Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage

FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage

0.82

CY2021Q4

cno

Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent

AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent

0.74

CY2021Q4

cno

Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent

AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent

0.64

CY2021Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11670700000

USD

CY2020Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

11744200000

USD

CY2021Q4

us-gaap

Policyholder Contract Deposits

PolicyholderContractDeposits

13689700000

USD

CY2020Q4

us-gaap

Policyholder Contract Deposits

PolicyholderContractDeposits

12540600000

USD

CY2021

us-gaap

Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense

ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the unpaid claims reserve (included in claims payable) and disabled life reserves related to accident and health insurance (included in the liability for future policy benefits) were as follows (dollars in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:58.086%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reinsurance (receivables) payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(881.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(993.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance, beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred claims related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on claim reserves</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid claims related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(802.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(766.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,144.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,123.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,218.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add reinsurance receivables (payables)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,742.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The reserves and liabilities we establish are necessarily based on estimates, assumptions and prior years' statistics. Such amounts will fluctuate based upon the estimation procedures used to determine the amount of unpaid losses. It is possible that actual claims will exceed our reserves and have a material adverse effect on our results of operations and financial condition.</span></div>

CY2021

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

64100000

USD

CY2020

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

-24000000.0

USD

CY2019

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

19200000

USD

CY2021

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

62600000

USD

CY2020

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

100500000

USD

CY2019

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

39300000

USD

CY2021

cno

Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate

IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate

126700000

USD

CY2020

cno

Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate

IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate

76500000

USD

CY2019

cno

Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate

IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate

58500000

USD

CY2021

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

0

USD

CY2020

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

-34000000.0

USD

CY2019

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

0

USD

CY2021

cno

Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items

IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems

0

USD

CY2020

cno

Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items

IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems

0

USD

CY2019

cno

Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items

IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems

-193700000

USD

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

126700000

USD

CY2020

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

42500000

USD

CY2019

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-135200000

USD

CY2020

cno

Income Tax Expense Benefit Net Operating Loss Cares Act

IncomeTaxExpenseBenefitNetOperatingLossCARESAct

-34000000

USD

CY2021

cno

Tax Refund Due To Cares Act

TaxRefundDueToCARESAct

80000000

USD

CY2021

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2020

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2019

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

0

CY2019

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.706

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Tax Exempt Income

EffectiveIncomeTaxRateReconciliationTaxExemptIncome

0.005

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Tax Exempt Income

EffectiveIncomeTaxRateReconciliationTaxExemptIncome

0.004

CY2019

us-gaap

Effective Income Tax Rate Reconciliation Tax Exempt Income

EffectiveIncomeTaxRateReconciliationTaxExemptIncome

0.010

CY2021

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.018

CY2020

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.016

CY2019

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.013

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.099

CY2019

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0

CY2021

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.223

CY2020

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.123

CY2019

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.493

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

241400000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards Domestic

DeferredTaxAssetsOperatingLossCarryforwardsDomestic

339200000

USD

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2300000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2700000

USD

CY2021Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

390700000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

386400000

USD

CY2021Q4

cno

Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets

DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets

158300000

USD

CY2020Q4

cno

Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets

DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets

105700000

USD

CY2021Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

27500000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

43000000.0

USD

CY2021Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

820200000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

877000000.0

USD

CY2021Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

48200000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Investments

DeferredTaxLiabilitiesInvestments

29500000

USD

CY2021Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

119400000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

133800000

USD

CY2021Q4

us-gaap

Deferred Tax Liabilities Other Comprehensive Income

DeferredTaxLiabilitiesOtherComprehensiveIncome

540400000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Other Comprehensive Income

DeferredTaxLiabilitiesOtherComprehensiveIncome

604300000

USD

CY2021Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

708000000.0

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

767600000

USD

CY2021Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

112200000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

109400000

USD

CY2021Q4

cno

Prepaid Accrued Income Taxes Current

PrepaidAccruedIncomeTaxesCurrent

6100000

USD

CY2020Q4

cno

Prepaid Accrued Income Taxes Current

PrepaidAccruedIncomeTaxesCurrent

90000000.0

USD

CY2021Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

118300000

USD

CY2020Q4

cno

Deferred Income Tax Assets Net Including Netof Current Income Tax Payable

DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable

199400000

USD

CY2021Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

112200000

USD

CY2019

cno

Payment Of Redemption Premium

PaymentOfRedemptionPremium

6100000

USD

CY2019

us-gaap

Write Off Of Deferred Debt Issuance Cost

WriteOffOfDeferredDebtIssuanceCost

1200000

USD

CY2018Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

193700000

USD

CY2019

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

-193700000

USD

CY2019Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

0

USD

CY2021Q4

cno

Loss Limitation Based On Income Of Life Insurance Company

LossLimitationBasedOnIncomeOfLifeInsuranceCompany

0.35

CY2021Q4

cno

Loss Limitation Based On Loss Of Non Life Entities

LossLimitationBasedOnLossOfNonLifeEntities

0.35

CY2021Q4

cno

Federal Long Term Tax Exempt Rate

FederalLongTermTaxExemptRate

0.0145

CY2021Q4

cno

Ownership Change Threshold Restricting Net Operating Loss Usage

OwnershipChangeThresholdRestrictingNetOperatingLossUsage

0.50

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.05

CY2009Q1

cno

Operating Loss Carryforward Limitation Numberof Rightsfor Each Share

OperatingLossCarryforwardLimitationNumberofRightsforEachShare

1

right

CY2009Q1

cno

Ownership Percentage Threshold Relating To Company382 Securities

OwnershipPercentageThresholdRelatingToCompany382Securities

0.0499

CY2009Q1

cno

Ownership Percentage Threshold Relating To Company382 Securities

OwnershipPercentageThresholdRelatingToCompany382Securities

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2010Q4

cno

Ownership Percentage Threshold Relating To Company382 Provision Ownership Percentageat Which Transfersof Common Stock Become Void

OwnershipPercentageThresholdRelatingToCompany382ProvisionOwnershipPercentageatWhichTransfersofCommonStockBecomeVoid

0.0499

CY2021Q4

us-gaap

Operating Loss Carryforwards

OperatingLossCarryforwards

1149400000

USD

CY2021Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2300000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards State And Local

DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

2700000

USD

CY2021Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

USD

CY2020Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

USD

CY2021Q4

us-gaap

Deferred Finance Costs Noncurrent Gross

DeferredFinanceCostsNoncurrentGross

12700000

USD

CY2020Q4

us-gaap

Deferred Finance Costs Noncurrent Gross

DeferredFinanceCostsNoncurrentGross

13800000

USD

CY2021Q4

us-gaap

Notes Payable

NotesPayable

1137300000

USD

CY2020Q4

us-gaap

Notes Payable

NotesPayable

1136200000

USD

CY2019

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-7300000

USD

CY2020

cno

Loss Contingency Insurance Related Assessment Expense Recognized

LossContingencyInsuranceRelatedAssessmentExpenseRecognized

2900000

USD

CY2019

cno

Loss Contingency Insurance Related Assessment Expense Recognized

LossContingencyInsuranceRelatedAssessmentExpenseRecognized

2100000

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

0

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

0

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

0

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

500000000.0

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

0

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal After Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

650000000.0

USD

CY2021Q4

us-gaap

Debt Instrument Carrying Amount

DebtInstrumentCarryingAmount

1150000000

USD

CY2021

us-gaap

Loss Contingency Disclosures

LossContingencyDisclosures

LITIGATION AND OTHER LEGAL PROCEEDINGS<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 9, 2019, Bankers Conseco Life Insurance Company ("BCLIC") and Washington National commenced an action entitled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action"). BCLIC and Washington National seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with Beechwood Re Ltd. ("BRe"), as well as for breaching its fiduciary duties to BCLIC and Washington National. The Court granted Wilmington's motion to dismiss this litigation. BCLIC and Washington National appealed the Court's decision. On April 20, 2021, the New York Appellate Division of the Supreme Court, First Judicial Department unanimously reversed the trial court and reinstated breach of contract and breach of fiduciary claims against Wilmington. The Wilmington Action is currently pending in the Supreme Court of the State of New York, County of New York, Commercial Division.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, CNO Financial Group, Inc., BCLIC, Washington National and 40|86 Advisors, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court. Plaintiffs seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities. Plaintiffs contend that the Agera securities were fraudulently transferred to the reinsurance trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties. The CNO Parties are vigorously contesting the plaintiff's claims. The CNO Parties had removed the case to the United States District Court for the District of Delaware but on April 6, 2020, the District Court granted the plaintiff's motion to remand the case back to the Delaware Chancery Court. Plaintiffs have filed an Amended Complaint and the CNO Parties have moved to dismiss the Amended Complaint. The Delaware Chancery Court denied the CNO Parties’ motions to dismiss the Amended Complaint on the basis of forum non conveniens, but granted the CNO Parties’ motion to stay the case pending the conclusion of a related matter. After the stay is lifted, the court will address the CNO Parties’ and other defendants’ motions to dismiss the Amended Complaint on numerous other grounds.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 28, 2019, BCLIC and Washington National commenced an action entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action"). BCLIC and Washington National seek an unspecified amount of damages, costs, attorney's fees, and other relief as the court deems appropriate. In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe. The Court granted KPMG’s motion to dismiss this litigation. BCLIC and Washington National appealed the Court's decision. On December 1, 2020, the New York Appellate Division of the Supreme Court, First Judicial Department unanimously reversed the trial court and reinstated the aiding and abetting claim against KPMG. The KPMG Action is currently pending in the Supreme Court of the State of New York, County of New York, Commercial Division.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Examinations and Fines</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance companies face significant risks related to regulatory investigations and actions. Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers. We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities. The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. Such examination has included </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of 42 states and the District of Columbia participated in this examination. In November 2018, we entered into an agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds (the "Global Resolution Agreement"). Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions is comparing expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guaranty Fund Assessments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet at December 31, 2021, included: (i) accruals of $6.8 million, representing our estimate of all known assessments that will be levied against the Company's insurance subsidiaries by various state guaranty associations based on premiums written through December 31, 2021; and (ii) receivables of $12.6 million that we estimate will be recovered through a reduction in future premium taxes as a result of such assessments. At December 31, 2020, such guaranty fund assessment accruals were $7.6 million and such receivables were $14.8 million. These estimates are subject to change when the associations determine more precisely the losses that have occurred and how such losses will be allocated among the insurance companies. We recognized expense for such assessments of $2.7 million, $2.9 million and $2.1 million in 2021, 2020 and 2019, respectively.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of the employment agreements of two of the Company's former chief executive officers, certain wholly-owned subsidiaries of the Company are the guarantors of the former executives' nonqualified supplemental retirement benefits. The liability for such benefits was $21.2 million and $22.0 million at December 31, 2021 and 2020, respectively, and is included in the caption "Other liabilities" in the consolidated balance sheet.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases and Certain Other Long-Term Commitments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents office space, equipment and computer software under contractual commitments or noncancellable operating lease agreements. Total expense pursuant to these agreements was $76.3 million, $74.9 million and $67.0 million in 2021, 2020 and 2019, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents office space for certain administrative operations under an agreement that expires in 2023. We lease sales offices in various states which are generally short-term in length with remaining lease terms expiring between 2022 and 2027. Many leases include an option to extend or renew the lease term. The exercise of the renewal option is at the Company's discretion. The operating lease liability includes lease payments related to options to extend or renew the lease term only if the Company is reasonably certain of exercising those options. In determining the present value of lease payments, the Company uses its incremental borrowing rate for borrowings secured by collateral commensurate with the terms of the underlying lease. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to our right of use assets are as follows (dollars in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:67.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets obtained in exchange for lease liabilities (non-cash transactions)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFhMmJkY2EzMzk1MDQyNWY5YTdjOTgzNjM5MDc3ODNmL3NlYzphYTJiZGNhMzM5NTA0MjVmOWE3Yzk4MzYzOTA3NzgzZl8yMDgvZnJhZzpmMmZhZGNjYmI5YTc0MWI2YTc2NGYzNTQ3MTBjMWYzZi90YWJsZTo1MmFmM2ZmYjkzNTY0MzlkYmVlNGNhZTMzMjU2NTJiNS90YWJsZXJhbmdlOjUyYWYzZmZiOTM1NjQzOWRiZWU0Y2FlMzMyNTY1MmI1XzUtMC0xLTEtMzEyNzE_15052569-ebf0-497e-8e64-91632c12f612"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFhMmJkY2EzMzk1MDQyNWY5YTdjOTgzNjM5MDc3ODNmL3NlYzphYTJiZGNhMzM5NTA0MjVmOWE3Yzk4MzYzOTA3NzgzZl8yMDgvZnJhZzpmMmZhZGNjYmI5YTc0MWI2YTc2NGYzNTQ3MTBjMWYzZi90YWJsZTo1MmFmM2ZmYjkzNTY0MzlkYmVlNGNhZTMzMjU2NTJiNS90YWJsZXJhbmdlOjUyYWYzZmZiOTM1NjQzOWRiZWU0Y2FlMzMyNTY1MmI1XzUtMC0xLTEtMzEyNzE_8bd5fceb-6c9a-4d5f-8014-9c820081219c">Total right of use assets</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of our operating lease liabilities as of December 31, 2021 are as follows (dollars in millions):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.403%"><tr><td style="width:1.0%"/><td style="width:77.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFhMmJkY2EzMzk1MDQyNWY5YTdjOTgzNjM5MDc3ODNmL3NlYzphYTJiZGNhMzM5NTA0MjVmOWE3Yzk4MzYzOTA3NzgzZl8yMDgvZnJhZzpmMmZhZGNjYmI5YTc0MWI2YTc2NGYzNTQ3MTBjMWYzZi90YWJsZTo3MzMxNzNlOWMyYzk0MzYwODUzYTgyMmZjNzEzZDM3Zi90YWJsZXJhbmdlOjczMzE3M2U5YzJjOTQzNjA4NTNhODIyZmM3MTNkMzdmXzgtMC0xLTEtMzEyNzE_d054c91f-e24a-4bd2-bf86-0200ff7c85e4"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFhMmJkY2EzMzk1MDQyNWY5YTdjOTgzNjM5MDc3ODNmL3NlYzphYTJiZGNhMzM5NTA0MjVmOWE3Yzk4MzYzOTA3NzgzZl8yMDgvZnJhZzpmMmZhZGNjYmI5YTc0MWI2YTc2NGYzNTQ3MTBjMWYzZi90YWJsZTo3MzMxNzNlOWMyYzk0MzYwODUzYTgyMmZjNzEzZDM3Zi90YWJsZXJhbmdlOjczMzE3M2U5YzJjOTQzNjA4NTNhODIyZmM3MTNkMzdmXzgtMC0xLTEtMzEyNzE_fef5a477-8965-40f3-bf5e-9d53c6194572">Present value of lease liabilities</span></span></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.403%"><tr><td style="width:1.0%"/><td style="width:77.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>

CY2011Q3

cno

Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws

NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws

42

state

CY2021

us-gaap

Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability

LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability

6800000

USD

CY2021Q4

us-gaap

Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset

LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset

12600000

USD

CY2020

us-gaap

Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability

LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability

7600000

USD

CY2020Q4

us-gaap

Loss Contingency Accrual Insurance Related Assessment Premium Tax Offset

LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset

14800000

USD

CY2021

cno

Loss Contingency Insurance Related Assessment Expense Recognized

LossContingencyInsuranceRelatedAssessmentExpenseRecognized

2700000

USD

CY2021

cno

Operating Leases And Sponsorship Agreements Expense

OperatingLeasesAndSponsorshipAgreementsExpense

76300000

USD

CY2020

cno

Operating Leases And Sponsorship Agreements Expense

OperatingLeasesAndSponsorshipAgreementsExpense

74900000

USD

CY2019

cno

Operating Leases And Sponsorship Agreements Expense

OperatingLeasesAndSponsorshipAgreementsExpense

67000000

USD

CY2021

us-gaap

Operating Lease Cost

OperatingLeaseCost

24600000

USD

CY2020

us-gaap

Operating Lease Cost

OperatingLeaseCost

25000000.0

USD

CY2021

us-gaap

Operating Lease Payments

OperatingLeasePayments

25700000

USD

CY2020

us-gaap

Operating Lease Payments

OperatingLeasePayments

25700000

USD

CY2021

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

17300000

USD

CY2020

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

11500000

USD

CY2021Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

48200000

USD

CY2020Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

54700000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

22600000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

16700000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

8200000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

3900000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

2000000.0

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due After Year Five

LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

100000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

53500000

USD

CY2021Q4

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

1200000

USD

CY2021Q4

us-gaap

Operating Lease Liability

OperatingLeaseLiability

52300000

USD

CY2021Q4

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P2Y10M24D

CY2021Q4

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.0185

CY2021

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

6700000

USD

CY2020

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

6000000

USD

CY2019

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

6100000

USD

CY2020Q1

cno

Stock Settled During Period Value

StockSettledDuringPeriodValue

1800000

USD

CY2021

us-gaap

Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net

DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

429400000

USD

CY2020

us-gaap

Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net

DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

120000000.0

USD

CY2019

us-gaap

Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net

DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

74300000

USD

CY2021

us-gaap

Stock Repurchased And Retired During Period Shares

StockRepurchasedAndRetiredDuringPeriodShares

16600000

shares

CY2020

us-gaap

Stock Repurchased And Retired During Period Shares

StockRepurchasedAndRetiredDuringPeriodShares

14500000

shares

CY2019

us-gaap

Stock Repurchased And Retired During Period Shares

StockRepurchasedAndRetiredDuringPeriodShares

15400000

shares

CY2021

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

402400000

USD

CY2020

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

263000000

USD

CY2019

us-gaap

Stock Repurchased And Retired During Period Value

StockRepurchasedAndRetiredDuringPeriodValue

252300000

USD

CY2021Q4

cno

Stock Repurchase Program Remaining Repurchase Authorized Amount

StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount

366900000

USD

CY2021Q4

us-gaap

Dividends Payable Current And Noncurrent

DividendsPayableCurrentAndNoncurrent

66100000

USD

CY2021

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.51

CY2020Q4

us-gaap

Dividends Payable Current And Noncurrent

DividendsPayableCurrentAndNoncurrent

67400000

USD

CY2020

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.47

CY2019Q4

us-gaap

Dividends Payable Current And Noncurrent

DividendsPayableCurrentAndNoncurrent

67200000

USD

CY2019

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.43

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.13

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.12

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.12

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.11

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.11

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.10

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

7800000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

4544000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.01

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2021

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

0

CY2021

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

1023000

shares

CY2021

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

18.01

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

7800000

USD

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

110000

shares

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

19.97

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

3411000

shares

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.28

CY2021

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

19200000

USD

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

2662000

shares

CY2021

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y7M6D

CY2021Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

15700000

USD

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

7845000

shares

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

6015000

shares

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

18.59

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2020

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

0

CY2020

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

1104000

shares

CY2020

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

16.59

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

9000000.0

USD

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

367000

shares

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

19.40

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

4544000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

19.01

CY2020

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y7M6D

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

27500000

USD

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

2946000

shares

CY2020

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y6M

CY2020Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

19900000

USD

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

8789000

shares

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

6539000

shares

CY2018Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

17.77

CY2019

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

801000

shares

CY2019

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

17.25

CY2019

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

787000

shares

CY2019

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

9.95

CY2019

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

5500000

USD

CY2019

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

538000

shares

CY2019

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

19.32

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

6015000

shares

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

18.59

CY2019

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y9M18D

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

38700000

USD

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

3517000

shares

CY2019

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y1M6D

CY2019Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

25800000

USD

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

4670000

shares

CY2021

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

18400000

USD

CY2020

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

16500000

USD

CY2019

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

6900000

USD

CY2020

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2021Q4

us-gaap

Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options

ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

3411000

shares

CY2021Q4

us-gaap

Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options

ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

2662000

shares

CY2009Q1

cno

Operating Loss Carryforward Limitation Numberof Rightsfor Each Share

OperatingLossCarryforwardLimitationNumberofRightsforEachShare

1

right

CY2021Q4

cno

Price Per One Thousandthof A Shareof Junior Preferred Stock

PricePerOneThousandthofAShareofJuniorPreferredStock

95.00

CY2021

cno

Preferred Stock Purchase Right Rights Would Become Exercisableinthe Eventany Personor Group Becomes Ownerofa Stated Percentage Percentage

PreferredStockPurchaseRightRightsWouldBecomeExercisableintheEventanyPersonorGroupBecomesOwnerofaStatedPercentagePercentage

0.0499

CY2021

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

441000000.0

USD

CY2020

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

301800000

USD

CY2019

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

409400000

USD

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

128400000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

142096000

shares

CY2019

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

156040000

shares

CY2021

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2726000

shares

CY2020

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1068000

shares

CY2019

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

1108000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

131126000

shares

CY2020

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

143164000

shares

CY2019

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

157148000

shares

CY2021

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4457700000

USD

CY2020

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4176000000

USD

CY2019

us-gaap

Direct Premiums Written

DirectPremiumsWritten

4311900000

USD

CY2021

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

20700000

USD

CY2020

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

23000000.0

USD

CY2019

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

25100000

USD

CY2021

us-gaap

Ceded Premiums Earned

CededPremiumsEarned

231300000

USD

CY2020

us-gaap

Ceded Premiums Earned

CededPremiumsEarned

247800000

USD

CY2019

us-gaap

Ceded Premiums Earned

CededPremiumsEarned

267900000

USD

CY2021

us-gaap

Premiums Written Net

PremiumsWrittenNet

4247100000

USD

CY2020

us-gaap

Premiums Written Net

PremiumsWrittenNet

3951200000

USD

CY2019

us-gaap

Premiums Written Net

PremiumsWrittenNet

4069100000

USD

CY2021

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

-900000

USD

CY2020

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

-9200000

USD

CY2019

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

7500000

USD

CY2021

cno

Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities

PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities

1905200000

USD

CY2020

cno

Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities

PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities

1620100000

USD

CY2019

cno

Premiums On Universal Life And Products Without Mortality And Morbidity Risk Additions To Insurance Liabilities

PremiumsOnUniversalLifeAndProductsWithoutMortalityAndMorbidityRiskAdditionsToInsuranceLiabilities

1743100000

USD

CY2021

cno

Premiums Earned Traditional Products With Mortality Or Morbidity Risk

PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk

2342800000

USD

CY2020

cno

Premiums Earned Traditional Products With Mortality Or Morbidity Risk

PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk

2340300000

USD

CY2019

cno

Premiums Earned Traditional Products With Mortality Or Morbidity Risk

PremiumsEarnedTraditionalProductsWithMortalityOrMorbidityRisk

2318500000

USD

CY2021

cno

Fees And Surrender Charges On Interest Sensitive Products

FeesAndSurrenderChargesOnInterestSensitiveProducts

180600000

USD

CY2020

cno

Fees And Surrender Charges On Interest Sensitive Products

FeesAndSurrenderChargesOnInterestSensitiveProducts

171000000.0

USD

CY2019

cno

Fees And Surrender Charges On Interest Sensitive Products

FeesAndSurrenderChargesOnInterestSensitiveProducts

162300000

USD

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2523400000

USD

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2511300000

USD

CY2019

us-gaap

Premiums Earned Net

PremiumsEarnedNet

2480800000

USD

CY2021Q4

us-gaap

Number Of States In Which Entity Operates

NumberOfStatesInWhichEntityOperates

4

state

CY2021

cno

Specified Percentage Of Total Collected Premiums That State Must Exceed To Be Identified

SpecifiedPercentageOfTotalCollectedPremiumsThatStateMustExceedToBeIdentified

0.05

CY2021

us-gaap

Insurance Commissions

InsuranceCommissions

116400000

USD

CY2020

us-gaap

Insurance Commissions

InsuranceCommissions

111800000

USD

CY2019

us-gaap

Insurance Commissions

InsuranceCommissions

133600000

USD

CY2021

cno

Salaries Wages And Officers Compensation Including Share Based Compensation

SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation

267900000

USD

CY2020

cno

Salaries Wages And Officers Compensation Including Share Based Compensation

SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation

252600000

USD

CY2019

cno

Salaries Wages And Officers Compensation Including Share Based Compensation

SalariesWagesAndOfficersCompensationIncludingShareBasedCompensation

238200000

USD

CY2021

cno

Operating Costs And Expenses Other

OperatingCostsAndExpensesOther

603000000.0

USD

CY2020

cno

Operating Costs And Expenses Other

OperatingCostsAndExpensesOther

577600000

USD

CY2019

cno

Operating Costs And Expenses Other

OperatingCostsAndExpensesOther

561100000

USD

CY2021

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

987300000

USD

CY2020

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

942000000.0

USD

CY2019

us-gaap

Other Cost And Expense Operating

OtherCostAndExpenseOperating

932900000

USD

CY2020Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1027800000

USD

CY2019Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1215500000

USD

CY2018Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1322500000

USD

CY2021

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

298800000

USD

CY2020

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

275800000

USD

CY2019

us-gaap

Deferred Policy Acquisition Costs Additions

DeferredPolicyAcquisitionCostsAdditions

288700000

USD

CY2021

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

252400000

USD

CY2020

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

233400000

USD

CY2019

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

195400000

USD

CY2021

cno

Deferred Policy Acquisition Cost Unrealized Investment Gains Losses

DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses

37800000

USD

CY2020

cno

Deferred Policy Acquisition Cost Unrealized Investment Gains Losses

DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses

-230100000

USD

CY2019

cno

Deferred Policy Acquisition Cost Unrealized Investment Gains Losses

DeferredPolicyAcquisitionCostUnrealizedInvestmentGainsLosses

-189600000

USD

CY2021

cno

Deferred Policy Acquisition Costs Other Adjustments

DeferredPolicyAcquisitionCostsOtherAdjustments

0

USD

CY2020

cno

Deferred Policy Acquisition Costs Other Adjustments

DeferredPolicyAcquisitionCostsOtherAdjustments

0

USD

CY2019

cno

Deferred Policy Acquisition Costs Other Adjustments

DeferredPolicyAcquisitionCostsOtherAdjustments

10700000

USD

CY2021Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1112000000

USD

CY2020Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1027800000

USD

CY2019Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

1215500000

USD

CY2020Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

249400000

USD

CY2019Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

275400000

USD

CY2018Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

343600000

USD

CY2021

us-gaap

Present Value Of Future Insurance Profits Amortization Expense1

PresentValueOfFutureInsuranceProfitsAmortizationExpense1

28700000

USD

CY2020

us-gaap

Present Value Of Future Insurance Profits Amortization Expense1

PresentValueOfFutureInsuranceProfitsAmortizationExpense1

34700000

USD

CY2019

us-gaap

Present Value Of Future Insurance Profits Amortization Expense1

PresentValueOfFutureInsuranceProfitsAmortizationExpense1

36700000

USD

CY2021

us-gaap

Present Value Of Future Insurance Profits Period Increase Decrease

PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease

1900000

USD

CY2020

us-gaap

Present Value Of Future Insurance Profits Period Increase Decrease

PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease

8700000

USD

CY2019

us-gaap

Present Value Of Future Insurance Profits Period Increase Decrease

PresentValueOfFutureInsuranceProfitsPeriodIncreaseDecrease

-14400000

USD

CY2021

cno

Present Valueof Future Profit Other Adjustments

PresentValueofFutureProfitOtherAdjustments

0

USD

CY2020

cno

Present Valueof Future Profit Other Adjustments

PresentValueofFutureProfitOtherAdjustments

0

USD

CY2019

cno

Present Valueof Future Profit Other Adjustments

PresentValueofFutureProfitOtherAdjustments

17100000

USD

CY2021Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

222600000

USD

CY2020Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

249400000

USD

CY2019Q4

us-gaap

Value Of Business Acquired Voba

ValueOfBusinessAcquiredVOBA

275400000

USD

CY2021Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year One

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearOne

0.11

CY2021Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Two

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearTwo

0.10

CY2021Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Three

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearThree

0.09

CY2021Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Four

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearFour

0.07

CY2021Q4

us-gaap

Present Value Of Future Insurance Profits Percentage Of Amortization Expense Year Five

PresentValueOfFutureInsuranceProfitsPercentageOfAmortizationExpenseYearFive

0.07

CY2021

us-gaap

Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits

InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits

0.05

CY2020

us-gaap

Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits

InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits

0.05

CY2019

us-gaap

Interest Accrual Rate Associated With Amortization Method Of Present Value Of Future Insurance Profits

InterestAccrualRateAssociatedWithAmortizationMethodOfPresentValueOfFutureInsuranceProfits

0.05

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

USD

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

USD

CY2019

us-gaap

Net Income Loss

NetIncomeLoss

409400000

USD

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

319500000

USD

CY2020

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

303900000

USD

CY2019

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

267900000

USD

CY2021

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

146500000

USD

CY2020

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

14100000

USD

CY2019

us-gaap

Increase Decrease In Accrued Income Taxes Payable

IncreaseDecreaseInAccruedIncomeTaxesPayable

-132800000

USD

CY2021

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

346200000

USD

CY2020

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

397600000

USD

CY2019

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

632400000

USD

CY2021

cno

Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments

ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments

-347600000

USD

CY2020

cno

Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments

ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments

-125200000

USD

CY2019

cno

Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments

ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments

-240700000

USD

CY2021

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

298800000

USD

CY2020

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

275800000

USD

CY2019

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

288700000

USD

CY2021

cno

Gain Losson Investments Excluding Cash Expenses

GainLossonInvestmentsExcludingCashExpenses

19100000

USD

CY2020

cno

Gain Losson Investments Excluding Cash Expenses

GainLossonInvestmentsExcludingCashExpenses

-36200000

USD

CY2019

cno

Gain Losson Investments Excluding Cash Expenses

GainLossonInvestmentsExcludingCashExpenses

28200000

USD

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

USD

CY2020

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

USD

CY2019

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-7300000

USD

CY2021

us-gaap

Other Operating Activities Cash Flow Statement

OtherOperatingActivitiesCashFlowStatement

10600000

USD

CY2020

us-gaap

Other Operating Activities Cash Flow Statement

OtherOperatingActivitiesCashFlowStatement

82900000

USD

CY2019

us-gaap

Other Operating Activities Cash Flow Statement

OtherOperatingActivitiesCashFlowStatement

70100000

USD

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

598300000

USD

CY2020

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

735500000

USD

CY2019

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

696700000

USD

CY2021

cno

Share Based Compensation Noncash Portion

ShareBasedCompensationNoncashPortion

26000000.0

USD

CY2020

cno

Share Based Compensation Noncash Portion

ShareBasedCompensationNoncashPortion

24500000

USD

CY2019

cno

Share Based Compensation Noncash Portion

ShareBasedCompensationNoncashPortion

19300000

USD

CY2021Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Balance

StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

1799600000

USD

CY2020Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Balance

StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

1805500000

USD

CY2021Q4

cno

Statutory Accounting Practices Statutory Asset Valuation Reserve

StatutoryAccountingPracticesStatutoryAssetValuationReserve

332500000

USD

CY2020Q4

cno

Statutory Accounting Practices Statutory Asset Valuation Reserve

StatutoryAccountingPracticesStatutoryAssetValuationReserve

304000000.0

USD

CY2021Q4

cno

Statutory Accounting Practices Statutory Interest Maintenance Reserve

StatutoryAccountingPracticesStatutoryInterestMaintenanceReserve

407900000

USD

CY2020Q4

cno

Statutory Accounting Practices Statutory Interest Maintenance Reserve

StatutoryAccountingPracticesStatutoryInterestMaintenanceReserve

406600000

USD

CY2021Q4

cno

Statutory Capital And Surplus Asset Valuation Reserve Interest Maintenance Reserve Total

StatutoryCapitalAndSurplusAssetValuationReserveInterestMaintenanceReserveTotal

2540000000

USD

CY2020Q4

cno

Statutory Capital And Surplus Asset Valuation Reserve Interest Maintenance Reserve Total

StatutoryCapitalAndSurplusAssetValuationReserveInterestMaintenanceReserveTotal

2516100000

USD

CY2021Q4

cno

Investments In Upstream Affiliates Included In Statutory Capital And Surplus

InvestmentsInUpstreamAffiliatesIncludedInStatutoryCapitalAndSurplus

42600000

USD

CY2020Q4

cno

Investments In Upstream Affiliates Included In Statutory Capital And Surplus

InvestmentsInUpstreamAffiliatesIncludedInStatutoryCapitalAndSurplus

42600000

USD

CY2021

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

277500000

USD

CY2020

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

409600000

USD

CY2019

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

291400000

USD

CY2020

cno

Statutory Accounting Practices Net Operating Income Cares Act

StatutoryAccountingPracticesNetOperatingIncomeCARESAct

99000000

USD

CY2020

cno

Statutory Accounting Practices Capital And Surplus Cares Act

StatutoryAccountingPracticesCapitalAndSurplusCARESAct

53000000

USD

CY2019

cno

Statutory Accounting Practices Income Tax Expense Benefit

StatutoryAccountingPracticesIncomeTaxExpenseBenefit

-46000000

USD

CY2019Q4

us-gaap

Statutory Accounting Practices Statutory Amount Available For Dividend Payments

StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments

46000000

USD

CY2021

cno

Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income

StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome

-11200000

USD

CY2020

cno

Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income

StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome

-11900000

USD

CY2019

cno

Statutory Accounting Practices Net Realized Capital Gain Loss Netof Tax Includedin Statutory Net Income

StatutoryAccountingPracticesNetRealizedCapitalGainLossNetofTaxIncludedinStatutoryNetIncome

-16600000

USD

CY2021

cno

Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income

StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome

164200000

USD

CY2020

cno

Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income

StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome

163800000

USD

CY2019

cno

Statutory Accounting Practices Pre Tax Feesand Interest Payable To Cno Or Its Nonlife Subsidiaries Includedin Statutory Net Income

StatutoryAccountingPracticesPreTaxFeesandInterestPayableToCNOOrItsNonlifeSubsidiariesIncludedinStatutoryNetIncome

166300000

USD

CY2021Q4

cno

Percentage Of Statutory Capital And Surplus Available For Dividend Distribution Without Prior Approval From Regulatory Agency

PercentageOfStatutoryCapitalAndSurplusAvailableForDividendDistributionWithoutPriorApprovalFromRegulatoryAgency

0.10

CY2021

cno

Amountof Dividends Paid By Insurance Subsidiaries

AmountofDividendsPaidByInsuranceSubsidiaries

328300000

USD

CY2021Q4

cno

Trended Adjusted Capitalto Riskbased Capital Ratio Threshold

TrendedAdjustedCapitaltoRiskbasedCapitalRatioThreshold

0.95

CY2021

cno

Numberof Product Lines

NumberofProductLines

3

product_line

CY2021

cno

Segment Revenues

SegmentRevenues

4076100000

USD

CY2020

cno

Segment Revenues

SegmentRevenues

3807500000

USD

CY2019

cno

Segment Revenues

SegmentRevenues

3910500000

USD

CY2021

cno

Interest Credited

InterestCredited

USD

CY2021

cno

Segment Expenses

SegmentExpenses

3605500000

USD

CY2020

cno

Segment Expenses

SegmentExpenses

3343700000

USD

CY2019

cno

Segment Expenses

SegmentExpenses

3542200000

USD

CY2021

us-gaap

Operating Income Loss

OperatingIncomeLoss

470600000

USD

CY2020

us-gaap

Operating Income Loss

OperatingIncomeLoss

463800000

USD

CY2019

us-gaap

Operating Income Loss

OperatingIncomeLoss

368300000

USD

CY2021

cno

Income Tax Benefit On Operating Income Loss

IncomeTaxBenefitOnOperatingIncomeLoss

105000000.0

USD

CY2020

cno

Income Tax Benefit On Operating Income Loss

IncomeTaxBenefitOnOperatingIncomeLoss

101500000

USD

CY2019

cno

Income Tax Benefit On Operating Income Loss

IncomeTaxBenefitOnOperatingIncomeLoss

78300000

USD

CY2021

cno

Operating Income Loss Net Of Tax

OperatingIncomeLossNetOfTax

365600000

USD

CY2020

cno

Operating Income Loss Net Of Tax

OperatingIncomeLossNetOfTax

362300000

USD

CY2019

cno

Operating Income Loss Net Of Tax

OperatingIncomeLossNetOfTax

290000000.0

USD

CY2021

us-gaap

Revenues

4122200000

USD

CY2020

us-gaap

Revenues

3821100000

USD

CY2019

us-gaap

Revenues

4015800000

USD

CY2021

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3554500000

USD

CY2020

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3476800000

USD

CY2019

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

3741600000

USD

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

567700000

USD

CY2020

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

344300000

USD

CY2019

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

274200000

USD

CY2021

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

126700000

USD

CY2020

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

76500000

USD

CY2019

cno

Income Tax Expense Benefit Before Valuation Allowance Adjustment

IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment

58500000

USD

CY2021

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

0

USD

CY2020

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-34000000.0

USD

CY2019

us-gaap

Deferred Other Tax Expense Benefit

DeferredOtherTaxExpenseBenefit

-193700000

USD

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

441000000.0

USD

CY2020

us-gaap

Net Income Loss

NetIncomeLoss

301800000

USD

CY2019

us-gaap

Net Income Loss

NetIncomeLoss

409400000

USD

CY2021Q4

us-gaap

Assets

36204400000

USD

CY2020Q4

us-gaap

Assets

35339900000

USD

CY2021Q4

us-gaap

Liabilities

30944700000

USD

CY2020Q4

us-gaap

Liabilities

29855700000

USD

CY2021Q1

us-gaap

Revenues

1006000000

USD

CY2021Q2

us-gaap

Revenues

1073100000

USD

CY2021Q3

us-gaap

Revenues

968300000

USD

CY2021Q4

us-gaap

Revenues

1074800000

USD

CY2021Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

190000000.0

USD

CY2021Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

101600000

USD

CY2021Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

128000000.0

USD

CY2021Q4

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

148100000

USD

CY2021Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

42600000

USD

CY2021Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

23600000

USD

CY2021Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

28200000

USD

CY2021Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

32300000

USD

CY2021Q1

us-gaap

Net Income Loss

NetIncomeLoss

147400000

USD

CY2021Q2

us-gaap

Net Income Loss

NetIncomeLoss

78000000.0

USD

CY2021Q3

us-gaap

Net Income Loss

NetIncomeLoss

99800000

USD

CY2021Q4

us-gaap

Net Income Loss

NetIncomeLoss

115800000

USD

CY2021Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

1.10

CY2021Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.59

CY2021Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.79

CY2021Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.95

CY2021Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

1.08

CY2021Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.58

CY2021Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.77

CY2021Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.93

CY2020Q1

us-gaap

Revenues

717200000

USD

CY2020Q2

us-gaap

Revenues

1014200000

USD

CY2020Q3

us-gaap

Revenues

1013500000

USD

CY2020Q4

us-gaap

Revenues

1076200000

USD

CY2020Q1

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-71000000.0

USD

CY2020Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

105400000

USD

CY2020Q3

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

166400000

USD

CY2020Q4

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

143500000

USD

CY2020Q1

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-49800000

USD

CY2020Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

23400000

USD

CY2020Q3

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

37200000

USD

CY2020Q4

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

31700000

USD

CY2020Q1

us-gaap

Net Income Loss

NetIncomeLoss

-21200000

USD

CY2020Q2

us-gaap

Net Income Loss

NetIncomeLoss

82000000.0

USD

CY2020Q3

us-gaap

Net Income Loss

NetIncomeLoss

129200000

USD

CY2020Q4

us-gaap

Net Income Loss

NetIncomeLoss

111800000

USD

CY2020Q1

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-0.15

CY2020Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.57

CY2020Q3

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.92

CY2020Q4

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

0.81

CY2020Q1

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.15

CY2020Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.57

CY2020Q3

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.91

CY2020Q4

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.80

CY2019

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

-5100000

USD

CY2021Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2022

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2022

86700000

USD

CY2021Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2023

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2023

228100000

USD

CY2021Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2024

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2024

246200000

USD

CY2021Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2025

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2025

208800000

USD

CY2021Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2026

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2026

143800000

USD

CY2021Q4

cno

Repaymentsof Investment Borrowings Relatedto Variable Interest Entities Amounts Duein2027

RepaymentsofInvestmentBorrowingsRelatedtoVariableInterestEntitiesAmountsDuein2027

98900000

USD

CY2021Q4

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2028

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2028

118200000

USD

CY2021Q4

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2029

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2029

13400000

USD

CY2021Q4

cno

Repayments Of Investment Borrowings Related To Variable Interest Entities Amounts Due In2030

RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntitiesAmountsDueIn2030

7000000

USD

CY2021Q4

cno

Variable Interest Entity Amortized Cost Securities Held

VariableInterestEntityAmortizedCostSecuritiesHeld

1206800000

USD

CY2021Q4

cno

Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities

VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities

2300000

USD

CY2021Q4

cno

Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities

VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities

5800000

USD

CY2021Q4

cno

Variable Interest Entity Fixed Maturity Securities Allowance For Credit Loss

VariableInterestEntityFixedMaturitySecuritiesAllowanceForCreditLoss

3700000

USD

CY2021Q4

cno

Variable Interest Entity Fixed Maturity Securities Fair Value

VariableInterestEntityFixedMaturitySecuritiesFairValue

1199600000

USD

CY2019

cno

Variable Interest Entities Investments Sold

VariableInterestEntitiesInvestmentsSold

280600000

USD

CY2021Q4

cno

Number Of Variable Interest Entity Investments Rated Below Investment Grade Continuous Unrealized Loss Position Exceeding20 Of Cost Basis

NumberOfVariableInterestEntityInvestmentsRatedBelowInvestmentGradeContinuousUnrealizedLossPositionExceeding20OfCostBasis

0

investment

CY2021

cno

Variable Interest Entities Net Realized Gain Loss On Investments

VariableInterestEntitiesNetRealizedGainLossOnInvestments

-3600000

USD

CY2021

cno

Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments

VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments

-7800000

USD

CY2021

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

11400000

USD

CY2021

cno

Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax

VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax

8100000

USD

CY2021

cno

Variable Interest Entities Investments Sold

VariableInterestEntitiesInvestmentsSold

70000000

USD

CY2020

cno

Variable Interest Entities Net Realized Gain Loss On Investments

VariableInterestEntitiesNetRealizedGainLossOnInvestments

13800000

USD

CY2020

cno

Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments

VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments

-8600000

USD

CY2020

cno

Variable Interest Entities Change In Allowance For Current Expected Credit Losses

VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses

-5200000

USD

CY2020

cno

Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax

VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax

8700000

USD

CY2020

cno

Variable Interest Entities Investments Sold

VariableInterestEntitiesInvestmentsSold

57400000

USD

CY2019

cno

Variable Interest Entities Net Realized Gain Loss On Investments

VariableInterestEntitiesNetRealizedGainLossOnInvestments

20500000

USD

CY2019

cno

Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments

VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments

-12400000

USD

CY2019

cno

Variable Interest Entity Gain Losson Dissolution

VariableInterestEntityGainLossonDissolution

-5100000

USD

CY2019

cno

Total Other Than Temporary Impairment Losses On Investments Held By Variable Interest Entities

TotalOtherThanTemporaryImpairmentLossesOnInvestmentsHeldByVariableInterestEntities

3000000

USD

CY2019

cno

Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax

VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax

12600000

USD

CY2021Q4

cno

Numberof Variable Interest Entitiesin Default

NumberofVariableInterestEntitiesinDefault

0

investment

Name	View Source	Status
0001224608-22-000012-index-headers.html	Edgar Link	pending
0001224608-22-000012-index.html	Edgar Link	pending
0001224608-22-000012.txt	Edgar Link	pending
0001224608-22-000012-xbrl.zip	Edgar Link	pending
cno-20211231.htm	Edgar Link	pending
cno-20211231.xsd	Edgar Link	pending
cno-20211231_cal.xml	Edgar Link	unprocessable
cno-20211231_def.xml	Edgar Link	unprocessable
cno-20211231_g1.jpg	Edgar Link	pending
cno-20211231_htm.xml	Edgar Link	completed
cno-20211231_lab.xml	Edgar Link	unprocessable
cno-20211231_pre.xml	Edgar Link	unprocessable
cno12312021ex21.htm	Edgar Link	pending
cno12312021ex231.htm	Edgar Link	pending
cno12312021ex311.htm	Edgar Link	pending
cno12312021ex312.htm	Edgar Link	pending
cno12312021ex321.htm	Edgar Link	pending
cno12312021ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2021 Q4 Form 10-K Financial Statement

#000122460822000012 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2021 Q4 Form 10-K Financial Statement

#000122460822000012 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno